Skip to main content

Angststörungen

  • Living reference work entry
  • First Online:
Psychiatrie, Psychosomatik, Psychotherapie

Zusammenfassung

Angststörungen zählen zu den häufigsten psychischen Störungen in der Allgemeinbevölkerung. Die Lebenszeitprävalenz liegt insgesamt bei 15–20 %. Diagnostisch werden folgende Untergruppen unterschieden: Panikstörung, die generalisierte Angststörung, die Agoraphobie, die soziale Phobie und die spezifischen Phobien. Ursache und Entstehung sind multifaktoriell bedingt. Angststörungen neigen häufig zu einem chronischen Krankheitsverlauf und gehen mit einer bedeutsamen psychosozialen Behinderung einher. Es existieren differenzierte störungsbezogene Ansätze von Pharmako- und Psychotherapie mit hohem Evidenz- und Empfehlungsgrad. Häufig ist auch eine Kombinationsbehandlung notwendig.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Abelson JL, Glitz D, Cameron OG et al (1991) Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. Arch Gen Psychiatry 48:157–162

    Article  CAS  PubMed  Google Scholar 

  • Abelson JL, Khan S, Liberzon I, Young EA (2007) HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety 24:66–76

    Article  PubMed  Google Scholar 

  • Acarturk C, Smit F, de Graaf R et al (2009) Incidence of social phobia and identification of its risk indicators: a model for prevention. Acta Psychiatr Scand 119:62–70

    Article  CAS  PubMed  Google Scholar 

  • Aderka IM (2009) Factors affecting treatment efficacy in social phobia: the use of video feedback and individual vs. group formats. J Anxiety Disord 23:12–17

    Article  PubMed  Google Scholar 

  • Agyropoulos SV, Nutt DJ (2003) Neurochemical aspects of anxiety. In: Nutt DJ, Ballenger JC (Hrsg) Anxiety disorders. Blackwell Science, Malden/Oxford, S 183–199

    Google Scholar 

  • Alamy S, Wei Zhang, Varia I et al (2008) Escitalopram in specific phobia: results of a placebo-controlled pilot trial. J Psychopharmacol 22:157–161

    Article  CAS  PubMed  Google Scholar 

  • Allen LB, Barlow DH (2006) Treatment of panic disorder: outcomes and basic processes. In: Rothbaum BO (Hrsg) Pathological anxiety: emotional processing in etiology and treatment. Guilford, New York, S 166–180

    Google Scholar 

  • Allgulander C (2010) Novel approaches to treatment of generalized anxiety disorder. Curr Opin Psychiatry 23:37–42

    Article  PubMed  Google Scholar 

  • Allgulander C, Hackett D, Salinas E (2001) Venlafaxine extended release (ER) in the treatment of generalized anxiety disorder: twenty-four-week placebo-controlled dose-ranging study. Br J Psychiatry 179:15–22

    Article  CAS  PubMed  Google Scholar 

  • Allgulander C, Dahl AA, Austin C et al (2004a) Efficacy of sertraline in a 12-week trial for generalized anxiety disorder. Am J Psychiatry 161:1642–1649

    Article  PubMed  Google Scholar 

  • Allgulander C, Mangano R, Zhang J et al (2004b) Efficacy of venlafaxine ER in patients with social anxiety disorder: a double-blind placebo-controlled, parallel-group comparison with paroxetine. Hum Psychopharmacol 19:387–396

    Article  CAS  PubMed  Google Scholar 

  • Allgulander C, Florea I, Huusom AK (2006) Prevention of relapse in generalized anxiety disorder by escitalopram treatment. Int J Neuropsychopharmacol 9:495–505

    Article  CAS  PubMed  Google Scholar 

  • Allgulander C, Hartford J, Russell J et al (2007) Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials. Curr Med Res Opin 23:1245–1252

    Article  CAS  PubMed  Google Scholar 

  • Allgulander C, Nutt D, Detke M et al (2008) A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder. J Psychopharmacol 22:417–424

    Article  CAS  PubMed  Google Scholar 

  • Alnas R (2001) Social phobia: research and clinical practice. Nord J Psychiatry 55:419–425

    Article  Google Scholar 

  • Alsene K, Deckert J, Sand P, de Wit H (2003) Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28(9):1694–1702

    Article  CAS  PubMed  Google Scholar 

  • Alvarez RP, Chen G, Bodurka J, Kaplan R, Grillon C (2011) Phasic and sustained fear in humans elicits distinct patterns of brain activity. Neuroimage 55:389–400

    Article  PubMed  Google Scholar 

  • Amiel JM, Mathew SJ (2007) Glutamate and anxiety disorders. Curr Psychiatry Rep 9:278–283

    Article  PubMed  Google Scholar 

  • Arch JJ, Craske MG (2009) First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives. Psychiatr Clin North Am 32:525–547

    Article  PubMed  Google Scholar 

  • Arnsten AFT (2009) Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci 10:410–422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Arntz A, Rauner M, van den Hout M (1995) „If I feel anxious, there must be danger“: ex-consequentia reasoning in inferring danger in anxiety disorders. Behav Res Ther 33:917–925

    Article  CAS  PubMed  Google Scholar 

  • Asmundson GJ, Katz J (2009) Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress Anxiety 26:888–901

    Article  PubMed  Google Scholar 

  • Austin DW, Richards JC (2001) The catastrophic misinterpretation model of panic disorder. Behav Res Ther 39:1277–1291

    Article  CAS  PubMed  Google Scholar 

  • Ayala ES, Meuret AE, Ritz T (2009) Treatments for blood-injury-injection phobia: a critical review of current evidence. J Psychiatr Res 43:1235–1242

    Article  PubMed  Google Scholar 

  • Bakish D, Huusom AKT, Legault M (2006) Escitalopram prevents relapse in generalized anxiety disorder: an analysis of date from Canadian patients participating in a multinational clinical study. Int J Neuropsychopharmacol 9:185–186

    Google Scholar 

  • Baldwin DS, Polkinghorn C (2005) Evidence-based pharmacotherapy of generalized anxiety disorder. Int J Neuropsychopharmacol 8:293–302

    Article  CAS  PubMed  Google Scholar 

  • Baldwin DS, Huusom AK, Maehlum E (2006) Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study. Br J Psychiatry 189:264–272

    Article  PubMed  Google Scholar 

  • Baldwin DS, Loft H, Florea I (2012) Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorder. Int Clin Psychopharmacol 27:197–207

    Article  PubMed  Google Scholar 

  • Balint M (1970) Therapeutische Aspekte der Regression: Die Theorie der Grundstörung. Klett-Cott, Stuttgart

    Google Scholar 

  • Ball SG, Kuhn A, Wall D et al (2005) Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline. J Clin Psychiatry 66:94–99

    Article  CAS  PubMed  Google Scholar 

  • Bandelow B (1995) The assessment of efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Int Clin Psychopharmacol 10:73–82

    Article  CAS  PubMed  Google Scholar 

  • Bandelow B, Baldwin DS (2009) Pharmacotherapy for panic disorder. In: Stein DJ, Hollander, Rothbaum BO (Hrsg) Textbook of anxiety disorders. American Psychiatric Publishing, Washington, DC/London, S 399–416

    Google Scholar 

  • Bandelow B, Seidler-Brandler U, Becker A et al (2007) Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World J Biol Psychiatry 8:175–187

    Article  PubMed  Google Scholar 

  • Bandelow B, Zohar J, Hollander E et al (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry 9:248–312

    Article  PubMed  Google Scholar 

  • Bandelow B, Chouinard G, Bobes J et al (2009) Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. Int J Neuropsychopharmacol 20:1–16

    Google Scholar 

  • Bandelow B, Chouinard G, Bobes J et al (2010) Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. Int J Neuropsychopharmacol 13:305–320

    Article  CAS  PubMed  Google Scholar 

  • Bandelow B, Wiltink J, Alpers GW, Benecke C, Deckert J, Eckhardt-Henn A, Ehrig C, Engel E, Falkai P, Geiser F, Gerlach AL, Harfst T, Hau S, Joraschky P, Kellner M, Kölner V, Kopp I, Langs G, Lichte T, Liebeck H, Matzat J, Reitt M, Rüddel HP, Rudolf S, Schick G, Schweiger U, Simon R, Springer A, Staats H, Ströhle A, Ströhm W, Waldherr B, Watzke B, Wedekind D, Zottl C, Zwanzger P, Beutel M (2013) Deutsche S3-Leitlinie zur Behandlung von Angststörungen

    Google Scholar 

  • Bandelow B, Reitt M, Röver C, Michaelis S, Görlich Y, Wedekind D (2015) Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol 30(4):183–92

    Article  PubMed  Google Scholar 

  • Baraldi M, Avallone R, Corsi L et al (2009) Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy. Metab Brain Dis 24:81–93

    Article  CAS  PubMed  Google Scholar 

  • Barlow DH (2000) Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory. Am Psychol 55:1245–1263

    Article  Google Scholar 

  • Barlow DH (2002) Anxiety and its disorders: the nature and treatment of anxiety and panic, 2. Aufl. Guilford, New York

    Google Scholar 

  • Barlow DH, Blanchard EB, Vermilyea JA et al (1986) Generalized anxiety and generalized anxiety disorder: description and reconceptualization. Am J Psychiatry 143:40–44

    Article  CAS  PubMed  Google Scholar 

  • Barlow DH, Gorman JM, Shear MK, Woods SW (2000) Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 283(19):2529–36

    Article  CAS  PubMed  Google Scholar 

  • Barrera TL, Norton PJ (2009) Quality of life impairment in generalized anxiety disorder, social phobia, and panic disorder. J Anxiety Disord 23:1089–1090

    Article  Google Scholar 

  • Batelaan NM, de Graaf R, Penninx BW, van Balkom AJ, Vollebergh WA, Beekman AT (2010) The 2-year prognosis of panic episodes in the general population. Psychol Med 40(1):147–157

    Article  CAS  PubMed  Google Scholar 

  • Batelaan NM, Spijker J, de Graaf R, Culipers P (2012) Mixed anxiety depression should not be included in DSM-5. J Nerv Ment Dis 200(6):495–498

    Article  PubMed  Google Scholar 

  • Beck AT (2005) Cognitive therapy: a 40-year retrospective. Arch Gen Psychiatry 62:953–959

    Article  PubMed  Google Scholar 

  • Beck AT, Emery G, Greenberg RL (1985) Anxiety disorders and phobias: a cognitive perspective. Basic Books, New York

    Google Scholar 

  • Beck AT, Epstein N, Brown G et al (1988) An inventory for measuring clinical anxiety. J Consult Clin Psychol 52:1090–1097

    Google Scholar 

  • Becker ES, Rinck M, Türke V et al (2007) Epidemiology of specific phobia subtypes: findings from the Dresden Mental Health Study. Eur Psychiatry 22:69–74

    Article  PubMed  Google Scholar 

  • Beesdo K, Knappe S, Pine DS (2009a) Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. Psychiatr Clin N Am 32:483–524

    Article  Google Scholar 

  • Beesdo K, Hartford J, Russell J et al (2009b) The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials. J Anxiety Disord 23:1064–1071

    Article  PubMed  Google Scholar 

  • Behar E, DiMarco ID, Hekler EB et al (2009) Current theoretical models of generalized anxiety disorder (GAD): conceptual review and treatment implications. J Anxiety Disord 23:1011–1023

    Article  PubMed  Google Scholar 

  • Beitman BD, Basha I, Flaker G (1987) Non-fearful panic disorder: panic attacks without fear. Behav Res Ther 25:487–492

    Article  CAS  PubMed  Google Scholar 

  • Bekker MH, van Mens-Verhulst J (2007) Anxiety disorders: sex differences in prevalence, degree, and background, but gender-neutral treatment. Gend Med 4:178–193

    Article  Google Scholar 

  • Belzer KD, McKee MB, Liebowitz MR (2005) Social anxiety disorder: current perspectives on diagnosis and treatment. Prim Psychiatry 12:35–48

    Google Scholar 

  • Bentz D, Michael T, de Quervain DJ, Wilhelm FH (2010) Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications. J Anxiety Disord 24:223–230

    Article  PubMed  Google Scholar 

  • Berger T, Hohl E, Caspar F (2009) Internet-based treatment for social phobia: a randomized controlled trial. J Clin Psychol 65:1021–1035

    Article  PubMed  Google Scholar 

  • Berman NC, Wheaton MG, McGrath P, Abramowitz JS (2010) Predicting anxiety: the role of experiential avoidance and anxiety sensitivity. J Anxiety Disord 24:109–113

    Article  PubMed  Google Scholar 

  • Bidzan L, Mahableshwarkar AR, Jacobsen P, Yan M, Sheehan DV (2012) Vortioxetine (Lu AA21004) in generalized anxiety disorder: results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial. Eur Neuropsychopharmacol 22:847–857

    Article  CAS  PubMed  Google Scholar 

  • Biederman J, Petty CR, Faraone SV et al (2006) Antecedents to panic disorder in nonreferred adults. J Clin Psychiatry 67:1179–1186

    Article  PubMed  Google Scholar 

  • Bielski RJ, Bose A, Chang C (2005) A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder. Ann Clin Psychiatry 17:65–69

    Article  PubMed  Google Scholar 

  • Birbaumer N, Grodd W, Diedrich O et al (1998) fMRI reveals amygdalae activation to human faces in social phobics. Neuroreport 9:1223–1226

    Article  CAS  PubMed  Google Scholar 

  • Birn RM, Shackman AJ, Oler JA, Williams LE, McFarlin DR, Rogers GM, Shelton SE, Alexander AL, Pine DS, Slattery MJ, Davidson RJ, Fox AS, Kalin NH (2014) Evolutionarily conserved prefrontal-amygdalar dysfunction in early-life anxiety. Mol Psychiatry 19:915–922

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Blair K, Geraci M, Devido J (2008) Neural response to self- and other referential praise and criticism in generalized social phobia. Arch Gen Psychiatry 65:1176–1184

    Article  PubMed  PubMed Central  Google Scholar 

  • Blanco C, Schneier FR, Vesga-López, Liebowitz MR (2009) Pharmacotherapy for social anxiety disorder. In: Stein DJ, Hollander, Rothbaum BO (Hrsg) Textbook of anxiety disorders. American Psychiatric Publishing, Washington, DC/London, S 471–499

    Google Scholar 

  • Blomhoff S, Haug TT, Hellstrom K et al (2001) Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry 179:23–30

    Article  CAS  PubMed  Google Scholar 

  • Blum K, Braverman ER, Wu S et al (1997) Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). Mol Psychiatry 2:239–246

    Article  CAS  PubMed  Google Scholar 

  • Bobes Garcia J, Montgomery S, Baldinetti F et al (2007) Pregabalin for the treatment of generalized anxiety disorder (GAD): efficacy and safety in elderly patients. Eur Psychiatry 22:280

    Article  Google Scholar 

  • Bolton JM, Cox BM, Afifi TO et al (2008) Anxiety disorders and risk for suicide attempts: findings from the Baltimore Epidemiologic Catchment area follow-up study. Depress Anxiety 25:477–481

    Article  PubMed  Google Scholar 

  • Bond M, Perry JC (2004) Long-term changes in defense styles with psychodynamic psychotherapy for depressive, anxiety, and personality disorders. Am J Psychiatry 161:1665–1671

    Article  PubMed  Google Scholar 

  • Bontempo A, Panza KE, Bloch MH (2012) d-Cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis. J Clin Psychiatry 73:533–537

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Borge FM, Hoffart A, Sexton H et al (2008) Residential cognitive therapy versus residential interpersonal therapy for social phobia: a randomized clinical trial. J Anxiety Disord 22:991–1010

    Article  PubMed  Google Scholar 

  • Borkovec ID (1994) The nature, functions and origins of worry. In: Davey GCL, Tallis F (Hrsg) Worrying: perspectives on theory, assessment, and treatment. Wiley, New York, S 5–23

    Google Scholar 

  • Borkovec TD (2006) Applied relaxation and cognitive therapy for pathological worry and generalized anxiety disorder. In: Davey GCL, Wells A (Hrsg) Worry in its psychological disorders: theory, assessment and treatment. Wiley, Chichester, S 273–287

    Chapter  Google Scholar 

  • Boschen MJ (2012) Pregabalin: dose-response relationship in generalized anxiety disorder. Pharmacopsychiatry 45:51–56

    Article  CAS  PubMed  Google Scholar 

  • Bouton ME, Mineka S, Barlow DH (2001) A modern learning theory perspective on the etiology of panic disorder. Psychol Rev 108:4–32

    Article  CAS  PubMed  Google Scholar 

  • Bouwer C, Stein DJ (1997) Association of panic disorder with a history of traumatic suffocation. Am J Psychiatry 154:1566–1570

    Article  CAS  PubMed  Google Scholar 

  • Bowlby J (1976) Trennung. Psychische Schäden als Folge der Trennung von Mutter und Kind. Kindler, München

    Google Scholar 

  • Bracha HS (2004) Freeze, flight, fight, fright, faint: adaptationist perspectives on the acute stress response spectrum. CNS Spectr 9:679–685

    Article  PubMed  Google Scholar 

  • Bracha HS (2006) Human brain evolution and the „neuroevolutionary time-depth principle“: implications for the reclassification of fear-circuitry-related traits in DSM-V and for studying resilience to warzone-related posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 30:827–853

    Article  PubMed  Google Scholar 

  • Bradwejn J, Ahokas A, Stein DJ et al (2005) Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study. Br J Psychiatry 187:352–359

    Article  PubMed  Google Scholar 

  • Brandt T (1996) Phobic postural vertigo. Neurology 46:1515–1519

    Article  CAS  PubMed  Google Scholar 

  • Brawman-Mintzer O, Lydiard RB (1997) Biological basis of generalized anxiety disorder. J Clin Psychiatry 58(Suppl 3):16–25

    CAS  PubMed  Google Scholar 

  • Brawman-Mintzer O, Lydiard RB, Emmanuel N, Payeur R, Johnson M, Roberts J, Jarrell MP, Ballenger JC (1993) Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry 150(8):1216–8

    Article  CAS  PubMed  Google Scholar 

  • Brawman-Mintzer O, Knapp RG, Nietert PJ (2005) Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study. J Clin Psychiatry 66:1321–1325

    Article  CAS  PubMed  Google Scholar 

  • Brawman-Mintzer O, Knapp RG, Rynn M et al (2006a) Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 67:874–881

    Google Scholar 

  • Brawman-Mintzer O, Nietert PJ, Rynn MA et al (2006b) Quetiapine monotherapy in patients with GAD. Paper presented at the annual meeting of the American Psychiatric Association, Toronto

    Google Scholar 

  • Briggs AC, Stretch DD, Brandon S (1993) Subtyping of panic disorder by symptom profile. Br J Psychiatry 163:201–209

    Article  CAS  PubMed  Google Scholar 

  • Britton JC, Rauch SL (2009) Neuroanatomy and neuroimaging of anxiety disorders. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 97–110

    Google Scholar 

  • Bruce TJ, Speigel DA, Gregg SF, Nuzzarello A (1995) Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. Am J Psychiatry 152:1156–1160

    Article  CAS  PubMed  Google Scholar 

  • Bruce SE, Machan JT, Dyck I, Keller MB (2001) Infrequency of „pure“ GAD: impact of psychiatric comorbidity on clinical course. Depress Anxiety 14:219–225

    Article  CAS  PubMed  Google Scholar 

  • Bruce SE, Yonkers KA, Otto MW et al (2005) Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 162:1179–1187

    Article  PubMed  PubMed Central  Google Scholar 

  • Buller R, Benkert O, Maier W (1986) Clinical subtypes in panic disorder: their descriptive and prospective validity. J Affect Disord 11:105–114

    Article  CAS  PubMed  Google Scholar 

  • Buller R, Maier W, Benkert O (1988) Das Paniksyndrom: Symptome, Verlauf, Prädiktoren. In: Hippius H, Ackenheil M, Engel RR (Hrsg) Angst – Leitsymptom psychiatrischer Erkrankungen. Springer, Berlin/Heidelberg/New York/Tokio, S 60–67

    Google Scholar 

  • Busch F, Milrod B (2004) Nature and treatment of panic disorder. In: Panksepp J (Hrsg) Textbook of biological psychiatry. Wiley, Hoboken, S 345–366

    Google Scholar 

  • Busch F, Cooper A, Klerman GL et al (1991) Neurophysiological, cognitive-behavioral, and psychoanalytic approaches to panic disorder: toward an integration. Psychoanal Inq 11:316–332

    Article  Google Scholar 

  • Busch F, Milrod B, Cooper A, Shapiro T (1996) Psychodynamic approaches to panic disorder. J Psychother Pract Res 5:73–83

    Google Scholar 

  • Busch FN, Milrod BL, Shear MK (2009) Psychodynamic concepts of anxiety. In: Stein DJ, Hollander, Rothbaum BO (Hrsg) Textbook of anxiety disorders. American Psychiatric Publishing, Washington, DC/London, S 117–128

    Google Scholar 

  • Butler G, Fennell M, Robson P, Gelder M (1991) Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol 59:167–175

    Article  CAS  PubMed  Google Scholar 

  • Bystritsky A (2006) Treatment-resistant anxiety disorders. Mol Psychiatry 11(9):805–814

    Article  CAS  PubMed  Google Scholar 

  • Cameron OG, Thyer BA, Nesse RM et al (1986) Symptom profiles of patients with DSM-III anxiety disorders. Am J Psychiatry 143:1132–1137

    Article  CAS  PubMed  Google Scholar 

  • Cammin-Nowak S, Helbig-Lang S, Lang T, Gloster AT, Fehm L, Gerlach AL, Ströhle A, Deckert J, Kircher T, Hamm AO, Alpers GW, Arolt V, Wittchen HU (2013) Specificity of homework compliance effects on treatment outcome in CBT: evidence from a controlled trial on panic disorder and agoraphobia. J Clin Psychol 69(6):616–629

    Article  PubMed  Google Scholar 

  • Canli T, Lesch KP (2007) Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci 10:1103–1109

    Article  CAS  PubMed  Google Scholar 

  • Canli T, Ferri J, Duman EA (2009) Genetics of emotion regulation. Neuroscience 164:43–54

    Article  CAS  PubMed  Google Scholar 

  • Carter CS, Braver TS, Barch DM et al (1998) Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 280(5364):747–749

    Article  CAS  PubMed  Google Scholar 

  • Charney DS (2003) Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatr Scand 108(Suppl 417):38–50

    Article  Google Scholar 

  • Charney DS, Drevets WD (2002) Neurobiological basis of anxiety disorders. In: Davis KL, Charney DS, Coyle JT et al (Hrsg) Neuropsychopharmacology: the fifth generation of progress. Lippincott Williams & Wilkins, Baltimore, S 901–930

    Google Scholar 

  • Charney DS, Heninger GR (1986) Abnormal regulation of noradrenergic function in panic disorders: effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 43:1042–1054

    Article  CAS  PubMed  Google Scholar 

  • Charney DS, Woods SW, Heninger GR (1989) Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder. Psychiatry Res 27:173–182

    Article  CAS  PubMed  Google Scholar 

  • Chessick CA, Allen MH, Thase M et al (2006) Azapirones for generalized anxiety disorder. Cochrane Database Syst Rev (3):CD006115

    Google Scholar 

  • Choy Y, Fer AJ, Lipsitz JD (2007) Treatment of specific phobia in adults. Clin Psychol Rev 27:266–286

    Article  PubMed  Google Scholar 

  • Christmas D, Hood S, Nutt D (2008) Potential novel anxiolytic drugs. Curr Pharm Des 14:3534–3546

    Article  CAS  PubMed  Google Scholar 

  • Cisler JM, Olatunji BO, Lohr JM (2009) Disgust, fear, and the anxiety disorders: a critical review. Clin Psychol Rev 29:34–46

    Article  PubMed  Google Scholar 

  • Clark DG, Agras WS (1991) The assessment and treatment of performance anxiety in musicians. Am J Psychiatry 148:598–605

    Article  CAS  PubMed  Google Scholar 

  • Clark DM, McManus F (2002) Information processing in social phobia. Biol Psychiatry 51:92–100

    Article  PubMed  Google Scholar 

  • Clark DM, Wells A (1995) A cognitive model of social phobia. In: Heimberg RG, Liebowitz MR, Hope DA et al (Hrsg) Social phobia: assessment and treatment. Guilford, New York, S 69–93

    Google Scholar 

  • Clark DM, Salkovskis PM, Hackmann A et al (1994) A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 164:759–769

    Article  CAS  PubMed  Google Scholar 

  • Clark DM, Salkovskis PM, Hackmann A et al (1999) Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol 67:583–589

    Article  CAS  PubMed  Google Scholar 

  • Clark DM, Ehlers A, McManus F et al (2003) Cognitive therapy versus fluoxetine in generalized social phobia: a randomized, placebo-controlled trial. J Consult Clin Psychol 71:1058–1067

    Article  PubMed  Google Scholar 

  • Clark DM, Ehlers A, Hackman A et al (2006) Cognitive therapy versus exposure and applied relaxation in social phobia: a randomized controlled trial. J Consult Clin Psychol 74:568–578

    Article  PubMed  Google Scholar 

  • Cloitre M, Shear MK (1995) Psychodynamic perspectives. In: Stein MB (Hrsg) Social phobia: clinical and research perspectives. American Psychiatric Press, Washington, DC, S 163–187

    Google Scholar 

  • Cloninger CR (1987) A systematic method für clinical description and classification of personality variants. Arch Gen Psychiatry 44:579–588

    Article  Google Scholar 

  • Cloos JM, Ferreira V (2009) Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatry 22:90–95

    Article  PubMed  Google Scholar 

  • Collegium Internationale Psychiatriae Scalarum (Hrsg) (1996) Internationale Skalen für Psychiatrie, 4. Aufl. Beltz, Göttingen

    Google Scholar 

  • Condren RM, Lucey JV, Thakore JH (2003) A preliminary study of baclofen-induced growth hormone release in generalised social phobia. Hum Psychopharmacol 18:125–130

    Article  CAS  PubMed  Google Scholar 

  • Cortese BM, Phan KL (2005) The role of glutamate in anxiety and related disorders. CNS Spectr 10:820–830

    Article  PubMed  Google Scholar 

  • Coupland NJ, Bell C, Potokar JP, Dorkins E, Nutt DJ (2000) Flumazenil in social phobia. Depress Anxiety 11:27–30

    Article  CAS  PubMed  Google Scholar 

  • Cowley DS, Roy-Byrne PP, Hommer D et al (1991) Benzodiazepine sensitivity in anxiety disorders. Biol Psychiatry 29:57 A

    Google Scholar 

  • Craig BAD (2009) How do you feel – now? The anterior insula and human awareness. Nat Rev Neurosci 10:59–70

    Article  CAS  PubMed  Google Scholar 

  • Craske MG, Barlow DH (2007) Mastery of your anxiety and panic (therapist guide), 4. Aufl. Oxford University Press, Oxford

    Google Scholar 

  • Craske MG, Waters AM (2005) Panic disorder, phobias, and generalized anxiety disorder. Annu Rev Clin Psychol 1:197–225

    Article  PubMed  Google Scholar 

  • Craske MG, Roy-Byrne PP, Stein MB et al (2009b) Treatment for anxiety disorders: efficacy to effectiveness to implementation. Behav Res Ther 47:931–937

    Article  PubMed  PubMed Central  Google Scholar 

  • Crestani F, Lorenz M, Baer K (1999) Decreased GABA-A receptor clustering results in enhanced anxiety and bias for threat cues. Nat Neurosci 2:833–839

    Article  CAS  PubMed  Google Scholar 

  • Crippa JA, Filho AS, Freitas MC, Zuardi AW (2007) Duloxetine in the treatment of social anxiety disorder. J Clin Psychopharmacol 27:310

    Article  PubMed  Google Scholar 

  • Crits-Christoph P, Crits-Christoph K, Wolf-Palacio D et al (1995) Brief supportive-expressive psychodynamic therapy for generalized anxiety disorder. In: Barber JP, Crits-Christoph P (Hrsg) Dynamic therapies for psychiatric disorders (axis I). Basic Books, New York, S 43–83

    Google Scholar 

  • Crits-Christoph P, Connolly MB, Azrian K et al (1996) Psychodynamic-interpersonal treatment of generalized anxiety disorder. Psychotherapy 33:418–430

    Article  Google Scholar 

  • Crum RM, Pratt LA (2001) Risk of heavy drinking and alcohol use disorders in social phobia: a prospective analysis. Am J Psychiatry 158:1693–1700

    Article  CAS  PubMed  Google Scholar 

  • Culpepper L (2009) Generalized anxiety disorder and medical illness. J Clin Psychiatry 70(Suppl 2):20–24

    Article  PubMed  Google Scholar 

  • Curtis GC, Magee WJ, Eaton WW, Wittchen HU (1998) Specific fears and phobias: epidemiology and classification. Br J Psychiatry 173:212–217

    Article  CAS  PubMed  Google Scholar 

  • Cuthbert B (2010) Early prevention in childhood anxiety disorders. Am J Psychiatry 167:1428–1430

    Article  PubMed  Google Scholar 

  • Dalton KM, Kalin NH, Grist TM, Davidson RJ (2005) Neural-cardiac coupling in threat evoked anxiety. J Cogn Neurosci 17:696–980

    Article  Google Scholar 

  • Darcis T, Ferreri M, Natens J et al (1995) A multicenter double-blind placebo-controlled study investigating the anxiolytic efficacy of hydroxyzine in patients with generalized anxiety. Hum Psychopharmacol 10:181–187

    Article  Google Scholar 

  • Davidson JR (2009) First-line pharmacotherapy approaches for generalized anxiety disorder. J Clin Psychiatry 2:25–31

    Article  Google Scholar 

  • Davidson JRT, Hughes DC, George LK et al (1993a) The epidemiology of social phobia: findings from the Duke epidemiological catchment area study. Psychol Med 23:709–718

    Article  CAS  PubMed  Google Scholar 

  • Davidson JRT, Potts NLS, Richichi EA et al (1993b) Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13:423–428

    Article  CAS  PubMed  Google Scholar 

  • Davidson JR, DuPont RL, Hedges D et al (1999) Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 60:528–535

    Article  CAS  PubMed  Google Scholar 

  • Davidson JR, Bose A, Korotzer A, Zheng H (2004) Escitalopram in the generalized anxiety disorder: double-blind, placebo controlled flexible-dose study. Depress Anxiety 19:234–240

    Article  CAS  PubMed  Google Scholar 

  • Davidson JR, Bose A, Wang Q (2005) Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder. J Clin Psychiatry 66:1441–1446

    Article  CAS  PubMed  Google Scholar 

  • Davidson J, Allgulander C, Pollack MH et al (2008a) Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. Hum Psychopharmacol 23:519–526

    Article  CAS  PubMed  Google Scholar 

  • Davis M (1998) Are different parts of the extended amygdala involved in fear versus anxiety. Biol Psychiatry 44:1239–1247

    Article  CAS  PubMed  Google Scholar 

  • Davis M, Myers KM, Chhatwal J, Ressler KJ (2006) Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy. NeuroRx 3:82–96

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Davis M, Walker DL, Miles L, Grillon C (2010) Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35:105–135

    Article  PubMed  Google Scholar 

  • De Masi F (2004) The psychodynamic of panic attacks: a useful integration of psychoanalysis and neuroscience. Int J Psychoanal 85:311–336

    Article  PubMed  Google Scholar 

  • Deci PA, Lydiard B, Santos AB (1992) Oral contraceptives and panic disorder. J Clin Psychiatry 53:163–165

    CAS  PubMed  Google Scholar 

  • Dembert ML, Dinneen MP, Opsahl MS (1994) Estrogen-induced panic disorder. Am J Psychiatry 151:1246

    CAS  PubMed  Google Scholar 

  • Demertzis KH, Craske MG (2005) Cognitive-behavioral therapy for anxiety disorders in primary care. Prim Psychiatry 12:52–58

    Google Scholar 

  • Demyttenaere K (2014) Agomelatine in treating generalized anxiety disorder. Expert Opin Investig Drugs 23:857–864

    Article  CAS  PubMed  Google Scholar 

  • Denys D, De Geus F (2005) Predictors of pharmacotherapy response in anxiety disorders. Curr Psychiatry Rep 7:252–257

    Article  PubMed  Google Scholar 

  • Derogatis LR, Lipman RS, Covi L (1976) Self-report symptom inventory. In: Guy W (Hrsg) ECDEU assessment manual for psychopharmacology. U.S. National Institute of Health, Psychopharmacology Research Branch, Rockville, MD, S 313–331

    Google Scholar 

  • Deutsch H (1928) Zur Genese der Platzangst. Int Z Psychoanal 14:297–314

    Google Scholar 

  • Dieterich M, Krafczyk S, Querner V, Brandt T (2001) Somatoform phobic postural vertigo and psychogenic disorders of stance and gait. Adv Neurol 87:225–233

    CAS  PubMed  Google Scholar 

  • Dilger S, Straube T, Mentzel HJ et al (2003) Brain activation to phobia-related pictures in spider phobic humans: an event-related functional magnetic resonance imaging study. Neurosci Lett 348:29–32

    Article  CAS  PubMed  Google Scholar 

  • Dodhia S, Hosanagar A, Fitzgerald DA, Labuschagne I, Wood AG, Nathan PJ, Phan KL (2014) Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder. Neuropsychopharmacology 39:2061–2069

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Domschke K, Dannlowski U (2010) Imaging genetics of anxiety disorders. Neuroimage 53:822–831

    Article  CAS  PubMed  Google Scholar 

  • Domschke K, Deckert J (2012) Genetics of anxiety disorders – status quo and quo vadis. Curr Pharm Des 18:5691–5698

    Article  CAS  PubMed  Google Scholar 

  • Domschke K, Deckert J (2017) Prävention von Angststörungen. In: Klosterkötter J, Maier W (Hrsg) Handbuch Prävention psychischer Störungen. Schattauer, Stuttgart (in Druck)

    Google Scholar 

  • Domschke K, Zwanzger P (2008) GABAergic and endocannabinoid dysfunction in anxiety – future therapeutic targets? Curr Pharm Des 14:3508–3517

    Article  CAS  PubMed  Google Scholar 

  • Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J, Hohoff C, Kersting A, Engelien A, Arolt V, Heindel W, Deckert J (2006) Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 9(3):349–355

    Article  CAS  PubMed  Google Scholar 

  • Domschke K, Stevens S, Pfleiderer B et al (2010) Interoceptive sensitivity in anxiety and anxiety disorders: an overview and integration of neurobiological findings. Clin Psychol Rev 30:1–11

    Article  PubMed  Google Scholar 

  • Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Holsboer F, Gerlach AL, Kircher T, Lang T, Alpers GW, Ströhle A, Fehm L, Gloster AT, Wittchen HU, Arolt V, Pauli P, Hamm A, Deckert J (2011) Neuropeptide S receptor gene – converging evidence for a role in panic disorder. Mol Psychiatry 16(9):938–948

    Article  CAS  PubMed  Google Scholar 

  • Domschke K, Tidow N, Kuithan H, Schwarte K, Klauke B, Ambrée O, Reif A, Schmidt H, Arolt V, Kersting A, Zwanzger P, Deckert J (2012) Monoamine oxidase A gene hypomethylation – a risk factor for panic disorder? Int J Neuropsychopharmacol 15:1217–1228

    Article  CAS  PubMed  Google Scholar 

  • Donovan MR, Glue P, Kolluri S, Emir B (2009) Comparative efficacy of antidepressants in preventing relapse in anxiety disorders – a meta-analysis. J Affect Disord 123:9–16

    Article  PubMed  CAS  Google Scholar 

  • Drenckhan I, Glöckner-Rist A, Rist F, Richter J, Gloster AT, Fehm L, Lang T, Alpers GW, Hamm AO, Fydrich T, Kircher T, Arolt V, Deckert J, Ströhle A, Wittchen HU, Gerlach AL (2015) Dimensional structure of bodily panic attack symptoms and their specific connections to panic cognitions, anxiety sensitivity and claustrophobic fears. Psychol Med 45(8):1675–1685

    Article  CAS  PubMed  Google Scholar 

  • Dresler T, Ehlis AC, Plichta MM, Richter MM, Jabs B, Lesch KP, Fallgatter AJ (2009) Panic disorder and a possible treatment approach by means of high-frequency rTMS: a case report. World J Biol Psychiatry 10(4 Pt 3):991–997

    Article  PubMed  Google Scholar 

  • Dresler T, Guhn A, Tupak S, Ehlis AC, Herrmann MJ, Fallgatter AF, Deckert J, Domschke K (2013) Revise the revised? – New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm 120:3–29

    Article  CAS  PubMed  Google Scholar 

  • Dugas MJ (2000) Generalized anxiety disorder publications: so where do we stand? J Anxiety Disord 14:31–40

    Article  CAS  PubMed  Google Scholar 

  • Dugas MJ, Robichaud M (2007) The cognitive-behavioral treatment of generalized anxiety disorder: from science to practice. Routledge, New York

    Google Scholar 

  • Dugas MI, Ladouceur RLE, Ereeston M et al (2003) Group cognitive-behavioral therapy for generalized anxiety disorder: treatment outcome and long-term follow-up. J Consult Clin Psychol 71:821–825

    Article  PubMed  Google Scholar 

  • Durham RC, Chambers JA, MacDonald RR et al (2003) Does cognitive-behavioural therapy influence the long-term course of generalized anxiety disorder? An 8–14 year follow-up of two clinical trials. Psychol Med 33:499–509

    Article  CAS  PubMed  Google Scholar 

  • Edelman RE, Chambless DL (1993) Compliance during sessions and homework in exposure-based treatment of agoraphobia. Behav Res Ther 31:767–773

    Article  CAS  PubMed  Google Scholar 

  • Ehlers A, Margraf J (1989) The psychophysiological model of panic attacks. In: Emmelkamp PMG, Everaerd WTAM, Kraaimaat F et al (Hrsg) Fresh perspectives on anxiety disorders. Swets & Zeitlinger, Amsterdam, S 1–29

    Google Scholar 

  • Eley TC (2009) The genetic basis of anxiety disorders. In: Andrews G, Charney DS, Sirovatka PJ, Regier DA (Hrsg) Stress-induced and fear circuitry disorders. Advancing the research agenda for DSM-V. AMER PSYCHIATRIC PRESS, INC, Washington, DC, S 145–158

    Google Scholar 

  • Emmelkamp PMG, Wittchen HU (2009) Specific phobias. In: Andrews G, Charney DS, Sirovatka PJ, Regier DA (Hrsg) Stress-induced and fear circuitry disorders. Advancing the research agenda for DSM-V. American Psychiatric Association, Arlington, VA, S 77–104

    Google Scholar 

  • Emmrich A, Beesdo-Baum K, Gloster AT, Knappe S, Höfler M, Arolt V, Deckert J, Gerlach AL, Hamm A, Kircher T, Lang T, Richter J, Ströhle A, Zwanzger P, Wittchen HU (2012) Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial. Psychother Psychosom 81(3):161–172

    Article  PubMed  Google Scholar 

  • Engel K, Bandelow B, Gruber O et al (2009) Neuroimaging in anxiety disorders. J Neural Transm 116:703–716

    Article  PubMed  Google Scholar 

  • Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, Specht M, Kohli MA, Kloiber S, Ising M, Heck A, Pfister H, Zimmermann P, Lieb R, Puetz B, Uhr M, Weber P, Deussing JM, Gonic M, Bunck M, Keßler MS, Frank E, Hohoff C, Domschke K, Krakowitzky P, Maier W, Bandelow B, Jacob C, Deckert J, Schreiber S, Strohmaier J, Noethen M, Cichon S, Rietschel M, Bettecken T, Keck ME, Landgraf R, Müller-Myhsok B, Holsboer F, Binder EB (2011) TMEM132D a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry 16:647–663

    Article  CAS  PubMed  Google Scholar 

  • Erwin BA, Heimberg RG, Juster H, Mindlin M (2002) Comorbid anxiety and mood disorder among persons with social anxiety disorder. Behav Res Ther 40:19–35

    Article  PubMed  Google Scholar 

  • ESEMeD/MHEDEA 2000 Investigators (2004) Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESMeD) project. Acta Psychiatr Scand 109(Suppl 420):21–27

    Article  Google Scholar 

  • Etkin A, Wager TD (2007) Functional neuroimaging of anxiety: a meta-analysis of emotional processing PTSD, social anxiety disorder, and specific phobia. Am J Psychother 164:1476–1488

    Google Scholar 

  • Evans S, Ferrando S, Findler M et al (2008) Mindfulness-based cognitive therapy for generalized anxiety disorder. J Anxiety Disord 22:716–721

    Article  PubMed  Google Scholar 

  • Eysenck HJ (1967) The biological basis of personality. CC Thomas, Springfield

    Google Scholar 

  • Eysenck MW (1991) Cognitive factors in clinical anxiety: potential relevance to therapy. In: Briley M, File SE (Hrsg) New concepts in anxiety. CRH Press, Boca Raton, S 418–433

    Chapter  Google Scholar 

  • Fahlen T, Nilsson HL, Borg K et al (1997) Social phobia: the clinical efficacy and tolerability of the monoamino oxidase-A and serotonin uptake inhibitor brofaromine: a double-blind, placebo-controlled study. J Clin Psychopharmacol 17:255–260

    Article  Google Scholar 

  • Faravelli C, Rosi S, Truglia E (2003) Benzodiazepines. In: Nutt D, Ballenger J (Hrsg) Anxiety disorders. Blackwell, Oxford, S 315–338

    Google Scholar 

  • Faravelli C, Furukawa TA, Truglia E (2009) Panic disorder. In: Andrews G, Charney DS, Sirovatka PJ, Regier DA (Hrsg) Stress-induced and fear circuitry disorders. Advancing the research agenda for DSM-V. American Psychiatric Association, Arlington, VA, S 31–58

    Google Scholar 

  • Fava L, Morton J (2009) Causal modelling of panic disorder theories. Clin Psychol Rev 29:623–637

    Article  PubMed  Google Scholar 

  • Fava GA, Zielezny M, Savron G, Grandi S (1995) Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry 166:87–92

    Article  CAS  PubMed  Google Scholar 

  • Fava GA, Grandi S, Rafanelli C et al (2001) Long-term outcome of social phobia treated by exposure. Psychol Med 31:899–905

    CAS  PubMed  Google Scholar 

  • Fava GA, Ruini C, Rafanelli C (2005) Sequential treatment of mood and anxiety disorders. J Clin Psychiatry 66:1392–1400

    Article  PubMed  Google Scholar 

  • Fedoroff IC, Taylor S (2001) Psychological and pharmacological treatments of social phobia: a meta-analysis. J Clin Psychopharmacol 21:311–324

    Article  CAS  PubMed  Google Scholar 

  • Fehm L, Margraf J (2002) Thought suppression: specificity in agoraphobia versus broad impairment in social phobia? Behav Res Ther 40(1):57–66

    Article  PubMed  Google Scholar 

  • Fehm L, Leissolo A, Furmark T, Wittchen HU (2005) Size and burden of social phobia in Europe. Eur Neuropsychopharmacol 15:453–462

    Article  CAS  PubMed  Google Scholar 

  • Feinstein JS, Buzza C, Hurlemann R, Follmer RL, Dahdaleh NS, Coryell WH, Welsh MJ, Tranel D, Wemmie JA (2013) Fear and panic in humans with bilateral amygdala damage. Nat Neurosci 16:270–272

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Feltner DE, Crockatt JG, Dubovsky SJ et al (2003) A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 23:240–249

    CAS  PubMed  Google Scholar 

  • Feltner D, Wittchen HU, Kavoussi R, Brock J, Baldinetti F, Pande AC (2008) Long-term efficacy of pregabalin in generalized anxiety disorder. Int Clin Psychopharmacol 23(1):18–28

    Article  PubMed  Google Scholar 

  • Ferguson JM, Khan A, Mangano R et al (2007) Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release. J Clin Psychiatry 68:58–68

    Article  CAS  PubMed  Google Scholar 

  • Feske U, Chambless DL (1995) Cognitive behaviour versus exposure treatment for social phobia: a meta-analysis. Behav Ther 26:695–720

    Article  Google Scholar 

  • Fisher PL (2006) The efficacy of psychological treatments for generalized anxiety disorder? In: Davey GCL, Wells A (Hrsg) Worry in its psychological disorders: theory, assessment and treatment. Wiley, Chichester, S 359–377

    Chapter  Google Scholar 

  • Fisher PL, Wells A (2009) Psychological models of worry and generalized anxiety disorder. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 225–237

    Google Scholar 

  • Foa EM, Davidson JRT, Huppert JD et al (2003) Comprehensive CBT, fluvoxamine, and their combination: a randomized placebo-controlled trial. Annual meeting of the Association for the Advancement of Behavior Therapy, 20–23 Nov, Boston

    Google Scholar 

  • Fonagy P, Target M (2003) Psychoanalytic theories. Perspectives from developmental psychopathology. Whurr, London/Philadelphia

    Google Scholar 

  • Freud S (1895) Über die Berechtigung von der Neurasthenie einen bestimmten Symptomenkomplex als „Angstneurose“ abzutrennen. Gesammelte Werke, Bd 1. Fischer, Frankfurt am Main, S 315–342, 1966 ff

    Google Scholar 

  • Freud S (1905) Drei Abhandlungen zur Sexualtheorie. GW 5:33–145

    Google Scholar 

  • Freud S (1909) Analyse der Phobie eines fünfjährigen Knaben. GW 8:241–377

    Google Scholar 

  • Freud S (1919) Wege der psychoanalytischen Therapie. GW 12:183–194

    Google Scholar 

  • Freud S (1926) Hemmung, Symptom und Angst. GW 14:111–205

    Google Scholar 

  • Furlan PM, DeMartinis N, Schweizer E et al (2001) Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress. Biol Psychiatry 50:254–259

    Article  CAS  PubMed  Google Scholar 

  • Furmark T, Tillfors M, Marteinsdottir I et al (2002) Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 59:425–433

    Article  PubMed  Google Scholar 

  • Furmark T, Tillfors M, Garpenstrand H et al (2004) Serotonin transporter polymorphism related to amygdale excitability and symptom severity in patients with social phobia. Neurosci Lett 362:189–192

    Article  CAS  PubMed  Google Scholar 

  • Furmark T, Carlbring P, Hedman E et al (2009) Guided and unguided self-help for social anxiety disorder: randomised controlled trial. Br J Psychiatry 195:440–447

    Article  PubMed  Google Scholar 

  • Furukawa TA, Watanabe N, Churchill R (2007) Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev CD004364

    Google Scholar 

  • Fyer AJ, Mannuzza S, Chapman TF et al (1995) Specificity in familial aggregation of phobic disorders. Arch Gen Psychiatry 52:564–573

    Article  CAS  PubMed  Google Scholar 

  • Fyer AJ, Hamilton SP, Durner M et al (2006) A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci. Biol Psychiatry 60:388–401

    Article  CAS  PubMed  Google Scholar 

  • Gabbard GO (1992) Psychodynamics of panic disorder and social phobia. Bull Menninger Clin 56(Suppl A):A3–A13

    CAS  PubMed  Google Scholar 

  • Gabbard GO (2005) Psychodynamic psychiatry in clinical practice, 4. Aufl. American Psychiatric Publishing, Washington, DC

    Google Scholar 

  • Gamble AL, Harvey AG, Rapee RM (2009) Specific phobia. In: Stein DJ, Hollander, Rothbaum BO (Hrsg) Textbook of anxiety disorders. American Psychiatric Publishing, Washington, DC/London, S 525–543

    Google Scholar 

  • Garakani A, Murrough JW, Charney DS, Bremner D (2009) The neurobiology of anxiety disorders. In: Charney DS, Nestler EJ (Hrsg) Neurobiology of mental illness, 3. Aufl. Oxford University Press, Oxford/New York, S 655–690

    Google Scholar 

  • Geiger M, Neufang S, Stein DJ, Domschke K (2014) Arousal and the attentional network in panic disorder. Hum Psychopharmacol 29:599–603

    Article  PubMed  Google Scholar 

  • Gelenberg A, Lydiard RB, Rudolph R et al (2000) Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6-month randomized controlled trial. JAMA 283:3082–3088

    Article  CAS  PubMed  Google Scholar 

  • Gelernter CS, Uhde TW, Cimbolic P et al (1991) Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Arch Gen Psychiatry 48:938–945

    Article  CAS  PubMed  Google Scholar 

  • Gerlach AL, Spellmeyer G, Vögele C, Huster R, Stevens S, Hetzel G, Deckert J (2006) Blood-injury phobia with and without a history of fainting: disgust sensitivity does not explain the fainting response. Psychosom Med 68(2):331–339

    Article  PubMed  Google Scholar 

  • Gloster AT, Wittchen HU, Einsle F et al (2011) Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. J Consult Clin Psychol 79(3):406–420

    Article  PubMed  Google Scholar 

  • Gloster AT, Klotsche J, Gerlach AL, Hamm A, Ströhle A, Gauggel S, Kircher T, Alpers GW, Deckert J, Wittchen HU (2014) Timing matters: change depends on the stage of treatment in cognitive behavioral therapy for panic disorder with agoraphobia. J Consult Clin Psychol 82(1):141–153

    Article  PubMed  Google Scholar 

  • Goldberg DP (2014) Anxious forms of depression. Depress Anxiety 31(4):344–351

    Article  PubMed  Google Scholar 

  • Goldin PR, Manber T, Hakimi S et al (2009) Neural bases of social anxiety disorder: emotional reactivity and cognitive regulation during social and physical threat. Arch Gen Psychiatry 66:170–180

    Article  PubMed  PubMed Central  Google Scholar 

  • Goodman WK, Bose A, Wang Q (2005) Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials. J Affect Disord 87:161–167

    Article  CAS  PubMed  Google Scholar 

  • Goodwin RD, Hamilton SP (2002) Early-onset fearful panic attack: a possible prodrome of early-onset severe psychopathology. Compr Psychiatry 43:22–27

    Article  PubMed  Google Scholar 

  • Gorman JM, Kent JM, Sullivan GM, Copan JD (2000) Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157:493–505

    Article  CAS  PubMed  Google Scholar 

  • Gould RA, Buckminster S, Pollack MH et al (1997) Cognitive-behavioral and pharmacological treatment for social phobia: a meta-analysis. Clin Psychol Sci Pract 4:291–306

    Article  Google Scholar 

  • Gould RA, Safren SA, Washington DON, Ott MW (2003) Cognitive-behavioral treatment for generalized anxiety disorder: a metaanalytic review. In: Mennin DS (Hrsg) Generalized anxiety disorder: advances in research and practice. Guilford, New York

    Google Scholar 

  • Grant BF, Hasin D, Blanco C et al (2005) The epidemiology of social phobia in the United States: results form the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 66:1351–1361

    Article  PubMed  Google Scholar 

  • Grant BF, Hasin DS, Stinson FS et al (2006) The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results form the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67:363–374

    Article  PubMed  Google Scholar 

  • Gray JA (1982) Precis of the neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. Behav Brain Sci 5:469–534

    Article  Google Scholar 

  • Gregory AM, Lau JYF, Eley TC (2008) Finding gene-environment interactions for phobias. Eur Arch Psychiatry Clin Neurosci 258:76–81

    Article  PubMed  Google Scholar 

  • Grös DF, Anthony MM (2006) The assessment and treatment of specific phobias: a review. Curr Psychiatry Rep 8:298–303

    Article  PubMed  Google Scholar 

  • Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L et al (2002) Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416:396–400

    Article  CAS  PubMed  Google Scholar 

  • Guastella AJ, Dadds MR, Lovibond PF et al (2007) A randomized controlled trial of the effect of d-cycloserine on exposure therapy for spider fear. J Psychiatr Res 41:466–471

    Article  PubMed  Google Scholar 

  • Guastella AJ, Richardson R, Lovibond PF et al (2008) A randomized controlled trial of d-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry 63:544–549

    Article  CAS  PubMed  Google Scholar 

  • Guastella AJ, Howard AL, Dadds MR et al (2009) A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 34:917–923

    Article  CAS  PubMed  Google Scholar 

  • Guhn A, Dresler T, Andreatta M, Müller LD, Hahn T, Tupak SV, Polak T, Deckert J, Herrmann MJ (2014) Medial prefrontal cortex stimulation modulates the processing of conditioned fear. Front Behav Neurosci 8:44

    Article  PubMed  PubMed Central  Google Scholar 

  • Guler O, Koken GN, Emul M et al (2008) Course of panic disorder during the early postpartum period: a prospective analysis. Compr Psychiatry 49:30–34

    Article  PubMed  Google Scholar 

  • Gureje O (2008) Comorbidity of pain and anxiety disorders. Curr Psychiatry Rep 10:318–322

    Article  PubMed  Google Scholar 

  • Haby MM, Donnelly M, Corry J, Vos T (2006) Cognitive behavioural therapy for depression, panic disorder and generalized anxiety disorder: a meta-regression of factors that may predict outcome. Aust N Z J Psychiatry 40:9–19

    Article  PubMed  Google Scholar 

  • Hackett D, Desmet A, Salinas EO (1999) Dose-response efficacy of venlafaxine XR in GAD. Poster presented at 11th world congress of psychiatry, Hamburg

    Google Scholar 

  • Haefely W (1990) Benzodiazepine receptor and ligands: structural and functional differences. In: Hindmarch I, Beaumont G, Brandon S et al (Hrsg) Benzodiazepines: current concepts: biological, clinical and social perspectives. Wiley, Chichester, S 1–18

    Google Scholar 

  • Hamilton M (1969) Diagnosis and rating of anxiety. In: Lader MH (Hrsg) Studies of anxiety. Br J Psychiatry (Spec Publ 3):76–79

    Google Scholar 

  • Hamilton M (1976) The Hamilton Anxiety Scale. In: Guy W (Hrsg) ECDEU assessment manual for psychopharmacology, rev edn. U.S. National Institute of Health, Psychopharmacology Research Branch, Rockville, MD, S 193–198

    Google Scholar 

  • Hamilton SP, Fyer AJ, Durner M et al (2003) Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci U S A 100:2550–2555

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hamm A (2006) Spezifische Phobien. Fortschritte der Psychotherapie. Hogrefe, Göttingen

    Google Scholar 

  • Hamm AO (2009) Specific phobias. Psychiatr Clin N Am 32:577–591

    Article  Google Scholar 

  • Hammack SE, Guo JD, Hazra R et al (2009) The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety. Prog Neuropsychopharmacol Biol Psychiatry 33:1309–1320

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hansen RA, Gaynes BN, Gartlehner G (2008) Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. Int Clin Psychopharmacol 23:170–179

    Article  PubMed  PubMed Central  Google Scholar 

  • Harding KJ, Skritskaya N, Doherty E et al (2008) Advances in understanding illness anxiety. Curr Psychiatry Rep 10:311–317

    Article  PubMed  Google Scholar 

  • Hariri AR, Mattay VS, Tessitore A et al (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400–403

    Article  CAS  PubMed  Google Scholar 

  • Hariri AR, Drabant EM, Munoz KE et al (2005) A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 62:146–152

    Article  CAS  PubMed  Google Scholar 

  • Harro J (2006) CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies. Amino Acids 31:215–230

    Article  CAS  PubMed  Google Scholar 

  • Hartford J, Kornstein S, Liebowitz M, Pigott T, Russell J, Detke M, Walker D, Ball S, Dunayevich E, Dinkel J, Erickson J (2007) Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial. Int Clin Psychopharmacol 22(3):167–74

    Article  PubMed  Google Scholar 

  • Hasler G, Nugent AC, Carlson PJ, Carson RE, Geraci M, Drevets WC (2008) Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch Gen Psychiatry 65(10):1166–1175

    Article  PubMed  Google Scholar 

  • Hawgood J, De Leo D (2008) Anxiety disorders and suicidal behaviour: an update. Curr Opin Psychiatry 21:51–64

    Article  PubMed  Google Scholar 

  • Hazlett-Stevens H, Pruitt LD, Collins A (2009) Phenomenology of generalized anxiety disorder. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 47–55

    Google Scholar 

  • Hedges DW, Brown BL, Shwalb DA et al (2007) The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials. J Psychopharmacol 21:102–111

    Article  CAS  PubMed  Google Scholar 

  • Heilig M (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38:213–224

    Article  CAS  PubMed  Google Scholar 

  • Heimberg RG (2003) Cognitive behavioral and psychotherapeutic strategies for social anxiety disorder. Annual meeting of the Anxiety Disorders Association of America, 27–30 Mar, Toronto

    Google Scholar 

  • Heimberg RG, Becker RE (2002) Cognitive-behavioral group therapy for social phobia: basic mechanisms and clinical strategies. Guilford, New York

    Google Scholar 

  • Heimberg RG, Hope DA, Dodge CS et al (1990) DSM-III-R subtypes of social phobia: comparison of generalized social phobics and public speaking phobics. J Nerv Ment Dis 173:172–179

    Article  Google Scholar 

  • Heimberg RG, Liebowitz MR, Hope DA et al (1998) Cognitive-behavioral group therapy vs. phenelzine therapy for social phobia: 2-week outcome. Arch Gen Psychiatry 55:1133–1141

    Article  CAS  PubMed  Google Scholar 

  • Heinrichs M, Domes G (2008) Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. Prog Brain Res 170:337–350

    Article  CAS  PubMed  Google Scholar 

  • Helbig-Lang S, Richter J, Lang T, Gerlach AL, Fehm L, Alpers GW, Ströhle A, Kircher T, Deckert J, Gloster AT, Wittchen HU (2014) The role of safety behaviors in exposure-based treatment for panic disorder and agoraphobia: associations to symptom severity, treatment course, and outcome. J Anxiety Disord 28(8):836–844

    Article  PubMed  Google Scholar 

  • Hettema JM (2008) What is the genetic relationship between anxiety and depression? Am J Med Genet Part C Semin Med Genet 148C:140–146

    Article  PubMed  Google Scholar 

  • Hettema JM, Neale MC, Kendler KS (2001) A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158:1568–1578

    Article  CAS  PubMed  Google Scholar 

  • Hettema JM, Prescott CA, Myers JM et al (2005) The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 62:182–189

    Article  PubMed  Google Scholar 

  • Hettema JM, An SS, Neale MC et al (2006a) Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry 11:752–762

    Article  CAS  PubMed  Google Scholar 

  • Hettema JM, Neale MC, Myers JM et al (2006b) A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry 163:857–864

    Article  PubMed  Google Scholar 

  • Hidalgo RB, Tupler LA, Davidson JR (2007) An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J Psychopharmacol 21(8):864–72

    Article  CAS  PubMed  Google Scholar 

  • Hicks TV, Leitenberg H, Barlow DH et al (2005) Physical, mental, and social catastrophic cognitions as prognostic factors in cognitive-behavioral and pharmacological treatment for panic disorder. J Consult Clin Psychol 73:506–514

    Article  PubMed  Google Scholar 

  • Hirshfeld D, Smoller J, Fredman S et al (1998) Early antecedents of panic disorder. Genes, childhood, and the environment. In: Rosenbaum JF, Pollack MH (Hrsg) Panic disorder and its treatment. Marcel Dekker, New York, S 93–151

    Google Scholar 

  • Hirshfeld-Becker DR, Micdo JA, Simoes NA, Henin A (2008) High risk studies and developmental antecedents of anxiety disorders. Am J Med Genet Part C Semin Med Genet 148C:99–117

    Article  PubMed  Google Scholar 

  • Hoehn-Saric R, McLeod DR, Zimmerli WD (1989) Somatic manifestations in women with generalized anxiety disorder: psychophysiological responses to psychological stress. Arch Gen Psychiatry 46:1113–1119

    Article  CAS  PubMed  Google Scholar 

  • Hoehn-Saric R, Hazlett RL, McLeod DR (1993) Generalized anxiety disorder with early and late onset of anxiety symptoms. Compr Psychiatry 34:291–298

    Article  CAS  PubMed  Google Scholar 

  • Hoehn-Saric R, Schlund MW, Wong SH (2005) Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder. Psychiatry Res 131:11–21

    Article  CAS  Google Scholar 

  • Hoffmann SO (2008) Psychodynamische Therapie von Angststörungen. Einführung und Manual für die kurz- und mittelfristige Therapie. Schattauer, Stuttgart/New York

    Google Scholar 

  • Hoffmann SO, Bassler M (1992) Psychodynamik und Psychotherapie von Angsterkrankungen. Nervenheilkunde 11:8–11

    Google Scholar 

  • Hoffmann SO, Bassler M (1995) „Manual“ für fokal orientierte psychoanalytische Psychotherapie bei Angststörungen. Erste Erfahrungen aus einer Therapiestudie. Forum Psa 11:2–14

    Google Scholar 

  • Hofmann SG (2007) Cognitive factors that maintain social anxiety disorder: a comprehensive model and its treatment implications. Cogn Behav Ther 36:193–209

    Article  PubMed  PubMed Central  Google Scholar 

  • Hofmann SG, Smits JA (2008) Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry 69:621–632

    Article  PubMed  PubMed Central  Google Scholar 

  • Hofmann SG, Meuret AE, Smits JA et al (2006) Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Arch Gen Psychiatry 63:298–304

    Article  CAS  PubMed  Google Scholar 

  • Hofmann SG, Sawyer AT, Korte KJ, Smits JA (2009) Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A meta-analytic review. Int J Cogn Ther 2:160–175

    Article  PubMed  PubMed Central  Google Scholar 

  • Holsboer F, Ising M (2008) Central CRH system in depression and anxiety – evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583:350–357

    Article  CAS  PubMed  Google Scholar 

  • Hood S, Potokar J, Davies S et al (2010) Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants. J Psychopharmacol 24:709–716

    Article  CAS  PubMed  Google Scholar 

  • Hope DA, Heimberg RG, Turk CL (2006) Managing social anxiety: a cognitive-behavioral therapy approach (therapist guide). Oxford University Press, Oxford/New York

    Google Scholar 

  • Hunot V, Churchill R, Silva de Lima M, Teixeira V (2007) Psychological therapies for generalized anxiety disorder. Cochrane Database Syst Rev CD001848

    Google Scholar 

  • Huppert JD, Sanderson WC (2009) Psychotherapy for generalized anxiety disorder. In: Stein DJ, Hollander E, Rothbaum BO (Hrsg) Anxiety disorders, 2. Aufl. American Psychiatric Publishing, Washington, DC/London, S 219–238

    Google Scholar 

  • Huppert D, Strupp M, Rettinger N et al (2005) Phobic postural vertigo – a long-term follow-up (5 to 15 years) of 106 patients. J Neurol 252:564–569

    Article  CAS  PubMed  Google Scholar 

  • Ipser JC, Kariuki CM, Stein DJ (2008) Pharmacotherapy for social anxiety disorder: a systematic review. Expert Rev Neurother 8:235–257

    Article  CAS  PubMed  Google Scholar 

  • Jacob RG, Redfern MS, Furman JM (2009) Space and motion discomfort and abnormal balance control in patients with anxiety disorders. J Neurol Neurosurg Psychiatry 80:74–78

    Article  CAS  PubMed  Google Scholar 

  • Jennings JH, Sparta DR, Stamatakis AM, Ung RL, Pleil KE, Kash TL, Stuber GD (2013) Distinct extended amygdala circuits for divergent motivational states. Nature 496:224–228

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Joëls M, Baram TZ (2009) The neuro-symphony of stress. Nat Rev Neurosci 10:459–466

    PubMed  PubMed Central  Google Scholar 

  • Joyce M, Khan A, Atkinson S et al (2008) Efficacy and safety of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder (GAD). Poster presented at the annual meeting of the American Psychiatric, Washington, DC

    Google Scholar 

  • Kaabi B, Gelernter J, Woods SW et al (2006) Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. Am J Hum Genet 78:543–553

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kagan J (1989) Temperamental contributions to social behavior. Am Psychol 44:668–674

    Article  Google Scholar 

  • Kalueff AV, Nutt DJ (2007) Role of GABA in anxiety and depression. Depress Anxiety 24:495–517

    Article  CAS  PubMed  Google Scholar 

  • Kampman M, Keijsers GPJ, Hoogduin CAL, Hendriks GJ (2002) A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone. J Clin Psychiatry 63:772–777

    Article  CAS  PubMed  Google Scholar 

  • Kamprath K, Romo-Parra H, Häring M, Gaburro S, Doengi M, Lutz B, Pape HC (2011) Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology 36(3):652–663

    Article  CAS  PubMed  Google Scholar 

  • Kapfhammer HP (2010) Psychotherapie und Pharmakotherapie. In: Adler RA, Joraschky P, Köhle K et al (Hrsg) Uexküll Psychosomatische Medizin. Modelle ärztlichen Denkens und Handelns, 7. Aufl. Urban & Fischer, München/Jena (im Druck)

    Google Scholar 

  • Kapfhammer HP, Fitz W, Huppert D, Grill E, Brandt T (2015) Acrophobia and visual height intolerance within conditions of anxiety and depression. Eur Arch Psychiatry Clin Neurosci 265:375–385

    Article  PubMed  Google Scholar 

  • Kaplan JR, Manuck SB, Fontenot MB, Mann JJ (2002) Central nervous system monoamine correlates of social dominance in cynomolgus monkeys (Macaca fascicularis). Neuropsychopharmacology 26:431–443

    Article  CAS  PubMed  Google Scholar 

  • Kasper S, Herman B, Nivoli G et al (2009) Efficacy of pregabalin and venlafaxine XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial. Int Clin Psychopharmacol 24:87–96

    Article  PubMed  Google Scholar 

  • Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Schläfke S, Dienel A (2014) Lavender oil preparation Silexan is effective in generalized anxiety disorder – a randomized, double-blind comparison to placebo and paroxetine. Int J Neuropsychopharmacol 17(6):859–869

    Article  CAS  PubMed  Google Scholar 

  • Kästner N, Richter SH, Lesch KP, Schreiber RS, Kaiser S, Sachser N (2015) Benefits of a „vulnerability gene“? A study in serotonin transporter knockout mice. Behav Brain Res 283:116–120

    Article  PubMed  CAS  Google Scholar 

  • Katon WJ (2006) Panic disorder. N Engl J Med 354:2360–2367

    Article  CAS  PubMed  Google Scholar 

  • Katschnig H, Amering M (1994) The long-term course of panic disorder. In: Wolfe BE, Maser JD (Hrsg) Treatment of panic disorder. A consensus development conference. American Psychiatric Press, Washington, DC/London, S 73–81

    Google Scholar 

  • Katschnig H, Stein MB, Buller R, The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia (1997) Moclobemide in social phobia: a double-blind, placebo-controlled clinical study. Eur Arch Psychiatry Clin Neurosci 247:71–80

    Article  Google Scholar 

  • Katz IR, Reynolds CF 3rd, Alexopoulos GS et al (2002) Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials. J Am Geriatr Soc 50:18–25

    Article  PubMed  Google Scholar 

  • Katzelnick DJ, Kobak KA, DeLeire T et al (2001) Impact of generalized social anxiety disorder in managed care. Am J Psychiatry 158:1999–2007

    Article  CAS  PubMed  Google Scholar 

  • Katzman MA (2009) Current considerations in the treatment of generalized anxiety disorder. CNS Drugs 23:103–120

    Article  CAS  PubMed  Google Scholar 

  • Keck ME, Ströhle A (2005) Challenge studies in anxiety disorders. Handb Exp Pharmacol 169:449–468

    Google Scholar 

  • Keller MB (2006) Social anxiety disorder clinical course and outcome: review of Harvard/Brown/Anxiety Research Project (HARP) findings. J Clin Psychiatry 12:14–19

    Google Scholar 

  • Kendler KS (1996) Major depression and generalized anxiety disorder: same genes, (partly) different environments – revisited. Br J Psychiatry 49:267–272

    Google Scholar 

  • Kendler KS, Neale M, Kessler R et al (1992a) The genetic epidemiology of phobias in women: the interrelationship of agoraphobia, social phobia, situational phobia and simple phobia. Arch Gen Psychiatry 49:273–281

    Article  CAS  PubMed  Google Scholar 

  • Kendler KS, Karkowski LM, Prescott CA (1999) Fears and phobias: reliability and heritability. Psychol Med 29:539–553

    Article  CAS  PubMed  Google Scholar 

  • Kendler KS, Myers J, Prescott CA, Neale MC (2001) The genetic epidemiology of irrational fears and phobias in men. Arch Gen Psychiatry 58:257–265

    Article  CAS  PubMed  Google Scholar 

  • Kendler KS, Jacobson KC, Myers J, Prescott CA (2002) Sex differences in genetic and environmental risk factors for irrational fears and phobias. Psychol Med 32:209–217

    Article  CAS  PubMed  Google Scholar 

  • Kent JM, Mathew SJ, Gorman JM (2002) Molecular targets in the treatment of anxiety. Biol Psychiatry 52:1008–1030

    Article  CAS  PubMed  Google Scholar 

  • Kessler RC, Berglund P, Demler O et al (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593–602

    Article  PubMed  Google Scholar 

  • Kessler RC, Ruscio AM, Shear K, Wittchen HU (2009) Epidemiology of anxiety disorders. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 19–33

    Google Scholar 

  • Kilts CD, Kelsey JE, Knight BT et al (2006) The neural correlates of social anxiety disorder and response to pharmacotherapy. Neuropsychopharmacology 31:2243–2253

    Article  CAS  PubMed  Google Scholar 

  • Kim TS, Pae CU, Yoon SJ et al (2006) Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder. Psychiatry Clin Neurosci 60:347–351

    Article  CAS  PubMed  Google Scholar 

  • Kim YW, Lee SH, Choi TK et al (2009) Effectiveness of mindfulness-based cognitive therapy as an adjuvant to pharmacotherapy in patients with panic disorder or generalized anxiety disorder. Depress Anxiety 26:601–606

    Article  PubMed  Google Scholar 

  • Kim SY, Adhikari A, Lee SY, Marshel JH, Kim CK, Mallory CS, Lo M, Pak S, Mattis J, Lim BK, Malenka RC, Warden MR, Neve R, Tye KM, Deisseroth K (2013) Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature 496:219–223

    Article  CAS  PubMed  Google Scholar 

  • Kircanski K, Craske MG, Epstein AM, Wittchen HU (2009) Subtypes of panic attacks: a critical review of the empirical literature. Depress Anxiety 26:878–887

    Article  PubMed  Google Scholar 

  • Klauke B, Deckert J, Reif A, Pauli P, Domschke K (2010) Life events in panic disorder-an update on „candidate stressors“. Depress Anxiety 27(8):716–730

    PubMed  Google Scholar 

  • Klauke B, Deckert J, Reif A, Pauli P, Zwanzger P, Baumann C, Arolt V, Glöckner-Rist A, Domschke K (2011) Serotonin transporter gene and childhood trauma – a GxE effect on anxiety sensitivity. Depress Anxiety 28:1048–1057

    Article  CAS  PubMed  Google Scholar 

  • Klein DF (1964) Delineation of two drug responsive anxiety syndromes. Psychopharmacologica (Berl) 5:397–408

    Article  CAS  Google Scholar 

  • Klein DF (1993) False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Arch Gen Psychiatry 50:306–317

    Article  CAS  PubMed  Google Scholar 

  • Klein DF (2002) Response differences of spontaneous panic and fear. Arch Gen Psychiatry 59:567–569

    Article  PubMed  Google Scholar 

  • Klein DF, Klein HM (1988) The status of panic disorder. Curr Opin Psychiatry 1:177–183

    Google Scholar 

  • Klein C, Milrod B, Busch F et al (2003) A process-outcome study of panic-focused psychodynamic psychotherapy. Psychoanal Inq 23:308–331

    Article  Google Scholar 

  • Klose M, Jacobi F (2004) Can gender differences in the prevalence of mental disorders be explained by sociodemographic factors? Arch Womens Ment Health 7:133–148

    Article  CAS  PubMed  Google Scholar 

  • Knappe S, Beesdo K, Fehm L et al (2009) Associations of familial risk factors with social fears and social phobia: evidence for the continuum hypothesis in social anxiety disorder? J Neural Transm 116:639–648

    Article  PubMed  Google Scholar 

  • Kobak KA, Griest JH, Jefferson JW, Katzelnick DJ (2002) Fluoxetine in social phobia: a double blind, placebo-controlled pilot study. J Clin Psychopharmacol 22:257–262

    Article  CAS  PubMed  Google Scholar 

  • Koenen KC, Amstadter AB, Ruggiero KJ et al (2009) RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety 26:309–315

    Article  PubMed  PubMed Central  Google Scholar 

  • Koenigs M, Grafman J (2009) Posttraumatic stress disorder: the role of medial prefrontal cortex and amygdale. Neuroscientist 15:540–548

    Article  PubMed  PubMed Central  Google Scholar 

  • Koponen H, Allgulander C, Erickson J, Dunayevich E, Pritchett Y, Detke MJ, Ball SG, Russell JM (2007) Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians. Prim Care Companion J Clin Psychiatry 9(2):100–7

    Article  PubMed  PubMed Central  Google Scholar 

  • von Korff MR, Eaton WW, Keyl PM (1985) The epidemiology of panic attacks and panic disorder: results of three community surveys. Am J Epidemiol 122:970–981

    Article  Google Scholar 

  • Kossowsky J, Pfaltz MC, Schneider S, Taeymans J, Locher C, Gaab J (2013) The separation anxiety hypothesis of panic disorder revisited: a meta-analysis. Am J Psychiatry 170:768–781

    Article  PubMed  Google Scholar 

  • Krieg JC, Bronisch T, Wittchen HU et al (1987) Anxiety disorders: a long-term prospective and retrospective follow-up study of former inpatients suffering from an anxiety neurosis or phobia. Acta Psychiatr Scand 76:36–47

    Article  CAS  PubMed  Google Scholar 

  • Kroenke K, Messina N, Benattia I et al (2006) Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder. J Clin Psychiatry 67:72–80

    Article  CAS  PubMed  Google Scholar 

  • Kushner MG, Beitman BD (1990) Panic attacks without fear: an overview. Behav Res Ther 28:469–479

    Article  CAS  PubMed  Google Scholar 

  • Kuzma JM, Black DW (2004) Integrating pharmacotherapy and psychotherapy in the management of anxiety disorders. Curr Psychiatry Rep 6:268–273

    Article  PubMed  Google Scholar 

  • König K (1981) Angst und Persönlichkeit. Das Konzept vom steuernden Objekt und seine Anwendungen. Vandenhoeck & Ruprecht, Göttingen

    Google Scholar 

  • LaBar KS, Cabeza R (2006) Cognitive neuroscience of emotional memory. Nat Rev Neurosci 7:54–64

    Article  CAS  PubMed  Google Scholar 

  • Lader MH, Gelder MG, Marks IM (1967) Palmar skin conductance measures as predictors of response to desensitization. J Psychosom Res 11:283–290

    Article  CAS  PubMed  Google Scholar 

  • Lader M, Scotto JC (1998) A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology (Berl) 139(4):402–6

    Article  CAS  Google Scholar 

  • Lader M, Stender K, Bürger V, Nil R (2004) Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study. Depress Anxiety 19(4):241–8

    Article  CAS  PubMed  Google Scholar 

  • Lanzenberger RR, Mitterhauser M, Spindelegger C et al (2007) Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 61:1081–1089

    Article  CAS  PubMed  Google Scholar 

  • Larson CL, Schaefer HS, Siegle GJ et al (2006) Fear is fast in phobic individuals: amygdala activation in response to fear-relevant stimuli. Biol Psychiatry 60:410–417

    Article  PubMed  Google Scholar 

  • Lau JY, Pine DS (2008) Elucidating risk mechanisms of gene environment interactions on pediatric anxiety: integrating findings from neuroscience. Eur Arch Psychiatry Clin Neurosci 258:97–106

    Article  PubMed  Google Scholar 

  • Laugharne J, Lillee A, Janca A (2010) Role of psychological trauma in the cause and treatment of anxiety and depressive disorders. Curr Opin Psychiatry 23:25–29

    Article  PubMed  Google Scholar 

  • Lawrence AE, Brown TA (2009) Classification and boundaries among anxiety-related problems. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 265–276

    Google Scholar 

  • Leahy RL, MvGinn LK, Busch FN, Milrod BL (2005) Anxiety disorders. In: Gabbard GO, Beck JS, Holmes J (Hrsg) Oxford textbook of psychotherapy. Oxford University Press, Oxford, S 137–161

    Google Scholar 

  • Ledgerwood L, Richardson R, Cranney J (2005) D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry 57(8):841–7

    Article  CAS  PubMed  Google Scholar 

  • LeDoux J (1998) The neural circuits underlying anxiety and fear. Biol Psychiatry 44:1229–1238

    Article  CAS  PubMed  Google Scholar 

  • LeDoux J (2007) The amygdale. Curr Biol 17:R868–R874

    Article  CAS  PubMed  Google Scholar 

  • Leenstra AS, Ormel J, Giel R (1995) Positive life change and recovery from depression and anxiety: a three-stage longitudinal study of primary care attenders. Br J Psychiatry 166:333–343

    Article  CAS  PubMed  Google Scholar 

  • Leichsenring F, Winkelbach C, Leibing E (2002) Die Generalisierte Angststörung – Krankheitsmuster, Diagnostik und Therapie. Z Psychosom Med Psychother 48:235–255

    PubMed  Google Scholar 

  • Leichsenring F, Rabung S, Leibing E (2004) The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 61:1208–1216

    Article  PubMed  Google Scholar 

  • Leichsenring F, Winkelbach C, Leibing E (2005) Psychoanalytisch-orientierte Fokaltherapie der Generalisierten Angststörung. Ein Manual. Psychotherapeut 50:258–264

    Article  Google Scholar 

  • Leichsenring F, Salzer S, Jaeger U et al (2009a) Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial. Am J Psychiatry 166:875–881

    Article  PubMed  Google Scholar 

  • Leichsenring F, Salzer S, Beutel ME (2009b) SOPHO-NET – Forschungsverbund zur Psychotherapie der sozialen Phobie. Psychother Psychosom Med Psychol 59:117–123

    Article  PubMed  Google Scholar 

  • Leichsenring F, Salzer S, Beutel ME, Herpertz S, Hiller W, Hoyer J, Huesing J, Joraschky P, Nolting B, Poehlmann K, Ritter V, Stangier U, Strauss B, Stuhldreher N, Tefikow S, Teismann T, Willutzki U, Wiltink J, Leibing E (2013) Psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: a multicenter randomized controlled trial. Am J Psychiatry 170:759–767

    Article  PubMed  Google Scholar 

  • Lenox-Smith AJ, Reynolds A (2003) A double-blind, randomised, placebo-controlled study of venlafaxine XR in patients with generalized anxiety disorder in primary care. Br J Gen Pract 53:772–777

    PubMed  PubMed Central  Google Scholar 

  • Lenze EJ (2009) Anxiety disorders in the elderly. In: Stein DJ, Hollander, Rothbaum BO (Hrsg) Textbook of anxiety disorders. American Psychiatric Publishing, Washington, DC/London, S 651–664

    Google Scholar 

  • Lenze EJ, Mulsant BH, Shear MK et al (2005) Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry 162:146–150

    Article  PubMed  Google Scholar 

  • Leonardo ED, Hen R (2006) Genetics of affective and anxiety disorders. Annu Rev Psychol 57:117–137

    Article  CAS  PubMed  Google Scholar 

  • Lesch KP, Bengel D, Heils A et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527–1531

    Article  CAS  PubMed  Google Scholar 

  • Levin FM (2009) Emotion and the psychodynamics of the cerebellum. A neuro-psychoanalytic analysis and synthesis. Karnac, London

    Google Scholar 

  • Levitan MN, Nardi AE (2009) Nocturnal panic attacks: clinical features and respiratory connections. Expert Rev Neurother 9(2):245–254

    Article  PubMed  Google Scholar 

  • Lieb R, Becker E, Altamura C (2005) The epidemiology of generalized anxiety disorder in Europe. Eur Neuropsychopharmacol 15:445–452

    Article  CAS  PubMed  Google Scholar 

  • Liebowitz MR (1987) Social phobia. Mod Probl Pharmacopsychiatry 22:141–173

    Article  CAS  PubMed  Google Scholar 

  • Liebowitz MR, Schneider F, Campeas R et al (1992) Phenelzine vs atenolol in social phobia: a placebo-controlled comparison. Arch Gen Psychiatry 49:290–300

    Article  CAS  PubMed  Google Scholar 

  • Liebowitz MR, Mangano RM, Bradwein J, Asnis G (2005c) A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. J Clin Psychiatry 66:238–247

    Article  CAS  PubMed  Google Scholar 

  • Liebowitz MR, Asnis G, Mangano R, Tzanis E (2009) A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder. J Clin Psychiatry 70:550–561

    Article  CAS  PubMed  Google Scholar 

  • Linden M, Zubrägel D, Bär T et al (2005) Efficacy of cognitive behaviour therapy in generalized anxiety disorders. Results of a controlled clinical trial (Berlin CBT-GAD Study). Psychother Psychosom 74:36–42

    Article  CAS  PubMed  Google Scholar 

  • Lipsitz JD, Gur M, Miller NL et al (2006) An open pilot study of interpersonal psychotherapy for panic disorder. J Nerv Ment Dis 194:440–445

    Article  PubMed  Google Scholar 

  • Lipsitz JD, Gur M, Vermes D et al (2008) A randomized trial of interpersonal psychotherapy versus supportive therapy of social anxiety disorder. Depress Anxiety 25:542–553

    Article  PubMed  Google Scholar 

  • Llorca PM, Spadone C, Sol O et al (2002) Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study. J Clin Psychiatry 63:1020–1027

    Article  CAS  PubMed  Google Scholar 

  • Lorberbaum JP, Kose S, Johnson MR et al (2004) Neural correlates of speech anticipatory anxiety in generalized social phobia. Neuroreport 15:2701–2705

    PubMed  Google Scholar 

  • Lott M, Greist JH, Jefferson JW et al (1997) Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study. J Clin Psychopharmacol 17:55–260

    Article  Google Scholar 

  • Lueken U, Straube B, Konrad C, Wittchen HU, Ströhle A, Wittmann A, Pfleiderer B, Uhlmann C, Arolt V, Jansen A, Kircher T (2013) Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. Am J Psychiatry 170(11):1345–1355

    Article  PubMed  Google Scholar 

  • Lydiard RB, Rickels K, Herman B, Feltner DE (2009) Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder. Int J Neuropsychopharmacol 9:1–13

    Google Scholar 

  • Machado S, Santos V, Paes F, Arias-Carrión O, Carta MG, Silva AC, Nardi AE (2014) Repetitive transcranial magnetic stimulation (rTMS) to treat refractory panic disorder patient: a case report. CNS Neurol Disord Drug Targets 13(6):1075–1078

    Article  CAS  PubMed  Google Scholar 

  • Magee WJ, Eaton WW, Wittchen HU et al (1996) Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 53:159–168

    Article  CAS  PubMed  Google Scholar 

  • Magee L, Erwin BA, Heimberg RG (2009) Psychological treatment of social anxiety disorder and specific phobia. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 334–349

    Google Scholar 

  • Mahableshwarkar AR, Jacobsen PL, Serenko M, Chen Y (2014a) A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder. Hum Psychopharmacol 29:64–72

    Article  CAS  PubMed  Google Scholar 

  • Mahableshwarkar AR, Jacobsen PL, Chen Y, Simon JS (2014b) A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder. Int J Clin Pract 68:49–59

    Article  CAS  PubMed  Google Scholar 

  • Makara GB, Mergl Z, Zelena D (2004) The role of vasopressin in hypothalamo-pituitary-adrenal axis activation during stress: an assessment of the evidence. Ann N Y Acad Sci 1018:151–161

    Article  CAS  PubMed  Google Scholar 

  • Malizia AL, Wilson SJ, Bell CM et al (1997) Neural correlates of anxiety provocation in social phobia. Neuroimage 5:301–305

    Google Scholar 

  • Marcin MS, Nemeroff CB (2003) The neurobiology of social anxiety disorder: the relevance of fear and anxiety. Acta Psychiatr Scand 108(Suppl 417):51–64

    Article  Google Scholar 

  • Margraf J, Ehlers A (1989) Etiological models of panic – psychophysiological and cognitive aspects. In: Baker R (Hrsg) Panic disorder: research and therapy. Wiley, London, S 205–231

    Google Scholar 

  • Marks IM (1981) Space ‚phobia‘. A pseudoagoraphobic syndrome. J Neurol Neurosurg Psychiatry 44:387–391

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marks IM (1987) Fears, phobias and rituals. Oxford University Press, New York

    Google Scholar 

  • Marks IM (1988) Blood-injury phobia: a review. Am J Psychiatry 145:1207–1214

    Article  CAS  PubMed  Google Scholar 

  • Marks IM, Swinson RP, Basoglu M et al (1993) Alprazolam and exposure alone and combined in panic disorder with agoraphobia. Br J Psychiatry 162:776–778

    Article  CAS  PubMed  Google Scholar 

  • Maron E, Shlik J (2006) Serotonin function in panic disorder: important, but why? Neuropsychopharmacology 31:1–11

    Article  CAS  PubMed  Google Scholar 

  • Maron E, Kuikka JT, Ulst K et al (2004) SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci 254:392–396

    Article  PubMed  Google Scholar 

  • Marshall RD (1995) Integrated treatment of social phobia. Bull Menninger Clin 59(Suppl A):A27–A37

    CAS  PubMed  Google Scholar 

  • Marteinsdottir I, Svensson A, Svedberg M et al (2007) The role of life events in social phobia. Nord J Psychiatry 61:207–212

    Article  PubMed  Google Scholar 

  • Martin EI, Ressler KJ, Binder E, Nemeroff CB (2009) The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin N Am 32:549–575

    Article  Google Scholar 

  • Mathew SJ, Ho S (2006) Etiology and neurobiology of social anxiety disorder. J Clin Psychiatry 12:9–13

    Google Scholar 

  • Mathew SJ, Coplan JD, Gorman JM (2001) Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry 158:1558–1567

    Article  CAS  PubMed  Google Scholar 

  • Mathew SJ, Amiel JM, Coplan JD et al (2005) Open-label trial of riluzole in generalized anxiety disorder. Am J Psychiatry 162:2379–2381

    Article  PubMed  Google Scholar 

  • Mathew SJ, Price RB, Charney DS (2008) Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. Am J Med Genet Part C Semin Med Genet 148C:89–98

    Article  CAS  PubMed  Google Scholar 

  • McCabe RE, Gifford S (2009) Psychological treatment of panic disorder and agoraphobia. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 308–320

    Google Scholar 

  • McGrath M, Kawachi I, Ascherio A et al (2004) Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry 161:1703–1705

    Article  PubMed  Google Scholar 

  • McHugh RK, Smits JA, Otto MW (2009) Empirically supported treatments for panic disorder. Psychiatr Clin North Am 32:593–610

    Article  PubMed  Google Scholar 

  • McLean CP, Anderson ER (2009) Brave men and timid women? A review of the gender differences in fear and anxiety. Clin Psychol Rev 29:496–505

    Article  PubMed  Google Scholar 

  • McNally RJ (1994) Choking phobia: a review of the literature. Compr Psychiatry 35:83–89

    Article  CAS  PubMed  Google Scholar 

  • McNally RJ, Eke M (1996) Anxiety sensitivity, suffocation fear, and breath-holding duration as predictors of response to carbon dioxide challenge. J Abnorm Psychol 105:146–149

    Article  CAS  PubMed  Google Scholar 

  • McNally RJ, Reese HE (2009) Information-processing approaches to understanding anxiety disorders. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 136–152

    Google Scholar 

  • Meissner WW (1991) Aggression in phobic states. Psychoanal Inq 11:261–283

    Article  Google Scholar 

  • Mentzos S (1984) Angstneurose. Psychodynamische und psychotherapeutische Aspekte. Fischer, Frankfurt/Main

    Google Scholar 

  • Mentzos S (2009) Lehrbuch der Psychodynamik. Die Funktion der Funktionalität psychischer Störungen. Vandenhoeck & Ruprecht, Göttingen

    Google Scholar 

  • Merikangas KR, Avenevoli S, Acharyya S et al (2002) The spectrum of social phobia in the Zürich cohort study of young adults. Biol Psychiatry 51:81–91

    Article  PubMed  Google Scholar 

  • Meyer JK, Maletic V (1991) The clinical and theoretical structures of adult phobias. Psychoanal Inq 11:333–350

    Article  Google Scholar 

  • Meyer-Lindenberg A (2008) Impact of prosocial neuropeptides on human brain function. Prog Brain Res 170:463–470

    Article  CAS  PubMed  Google Scholar 

  • Miller LA, Taber KH, Gabbard GO, Hurley RA (2005) Neural underpinnings of fear and its modulation: implications. J Neuropsychiatry Clin Neurosci 17:1–6

    Article  PubMed  Google Scholar 

  • Milrod BL, Shear MK (1991a) Dynamic treatment of panic disorder: a review. J Nerv Ment Dis 179:741–743

    Article  CAS  PubMed  Google Scholar 

  • Milrod BL, Shear MK (1991b) Psychodynamic treatment of panic: three case histories. Hosp Community Psychiatry 42:311–312

    CAS  PubMed  Google Scholar 

  • Milrod BL, Busch F, Cooper A, Shapiro T (1997) Manual of panic-focused psychodynamic psychotherapy. American Psychiatric Press, Washington, DC/London

    Google Scholar 

  • Milrod B, Busch F, Leon AC et al (2000) Open trial of psychodynamic psychotherapy for panic disorder: a pilot study. Am J Psychiatry 157:1878–1880

    Article  CAS  PubMed  Google Scholar 

  • Milrod B, Busch F, Leon AC et al (2001) A pilot open trial of brief psychodynamic psychotherapy for panic disorder. J Psychother Pract Res 10:239–245

    CAS  PubMed  PubMed Central  Google Scholar 

  • Milrod B, Leon AC, Busch F et al (2007) A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry 164:265–272

    Article  PubMed  Google Scholar 

  • Mineka S, Zinbarg R (2006) A contemporary learning theory perspective on the etiology of anxiety disorders: it’s not what you thought it was. Am Psychol 61:10–26

    Article  PubMed  Google Scholar 

  • Mirza NR, Bright JL, Stanhope KJ et al (2005) Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels? Psychopharmacology (Berl) 180:159–168

    Article  CAS  Google Scholar 

  • Mitte K (2005) A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord 88:27–45

    Article  PubMed  Google Scholar 

  • Mitte K, Noack P, Steil R, Hautzinger M (2005) A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. J Clin Psychopharmacol 25:141–150

    Article  CAS  PubMed  Google Scholar 

  • Moffitt TE, Harrington H, Caspi A et al (2007) Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry 64:651–660

    Article  PubMed  Google Scholar 

  • Möhler H, Fritschy JM, Crestani F et al (2004) Specific GABAA circuits in brain development and therapy. Biochem Pharmacol 68:1685–1690

    Article  PubMed  CAS  Google Scholar 

  • Möller HJ, Volz HP, Reimann IW, Stoll KD (2001) Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group. J Clin Psychopharmacol 21:59–65

    Article  PubMed  Google Scholar 

  • Montgomery SA, Nil R, Durr-Pal N et al (2005) A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. J Clin Psychiatry 66:1270–1278

    Article  CAS  PubMed  Google Scholar 

  • Montgomery SA, Tobias K, Zornberg GL et al (2006) Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. J Clin Psychiatry 67:771–782

    Article  CAS  PubMed  Google Scholar 

  • Montgomery S, Chatamra K, Pauer L et al (2008) Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. Br J Psychiatry 193:389–394

    Article  PubMed  Google Scholar 

  • Morreale M, Tancer ME, Uhde TW (2009) Pathogenesis of social anxiety disorder. In: Stein DJ, Hollander, Rothbaum BO (Hrsg) Textbook of anxiety disorders. American Psychiatric Publishing, Washington, DC/London, S 453–469

    Google Scholar 

  • Morris EP, Stewart SH, Ham LS (2005) The relationship between social anxiety disorder and alcohol use disorders: a critical review. Clin Psychol Rev 25:734–760

    Article  PubMed  Google Scholar 

  • Morrison KH, Bradley R, Westen D (2003) The external validity of controlled clinical trials of psychotherapy for depression and anxiety: a naturalistic study. Psychol Psychother 76:109–132

    Article  PubMed  Google Scholar 

  • Mowrer OH (1947) On the dual nature of learning – a reinterpretation of „conditioning“ and „problem solving“. Harv Educ Rev 17:102–148

    Google Scholar 

  • Mühlbacher M, Nickel MK, Nickel C et al (2005) Mirtazapine treatment of social phobia in women: a randomized, double-blind placebo-controlled study. J Clin Psychopharmacol 25:580–583

    Article  Google Scholar 

  • Munjack DJ, Baltazar PL, DeQuattro V et al (1990) Generalized anxiety disorder: some biochemical aspects. Psychiatry Res 32:35–43

    Article  CAS  PubMed  Google Scholar 

  • Murray L, Creswell C, Cooper PJ (2009) The development of anxiety disorders in childhood: an integrative review. Psychol Med 39:1413–1423

    Article  CAS  PubMed  Google Scholar 

  • Murray CJ, Abraham J, Ali MK, Alvarado M, Atkinson C, Baddour LM, US Burden of Disease Collaborators et al (2013) The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA 310:591–608

    Article  CAS  PubMed  Google Scholar 

  • Nardi AE, Lopes FL, Freire RC et al (2009) Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Psychiatry Res 169:149–153

    Article  PubMed  Google Scholar 

  • Nemeroff CB (2003) The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 37:133–146

    PubMed  Google Scholar 

  • Nemiah JC (1981) A psychoanalytic view of phobias. Am J Psychoanal 41:115–120

    Article  CAS  PubMed  Google Scholar 

  • Neumeister A, Bain E, Nugent AC et al (2004) Reduced serotonin 1A receptor binding in panic disorder. J Neurosci 24:589–591

    Article  CAS  PubMed  Google Scholar 

  • Neumeister A, Daher RJ, Charney DS (2005) Anxiety disorders: noradrenergic neurotransmission. Handb Exp Pharmacol 169:205–223

    Google Scholar 

  • Newman MG, Castonguay LG, Borkovec TD, Molnar C (2004) Integrative psychotherapy. In: Heimberg RG, Turk CL (Hrsg) Generalized anxiety disorder: advances in research and practice. Guilford, New York, S 320–350

    Google Scholar 

  • Nimatoudis I, Zissis NP, Kogeorgos J et al (2004) Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder: a double-blind, randomized, placebo controlled study. Int Clin Psychopharmacol 19:331–336

    Article  CAS  PubMed  Google Scholar 

  • Ninan PT, Dunlop BW (2005) Neurobiology and etiology of panic disorder. J Clin Psychiatry 66(Suppl 4):3–7

    PubMed  Google Scholar 

  • Nitschke JB, Sarinopoulos I, Oathes DJ et al (2009) Anticipatory activation in the amygdale and anterior cingulated in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry 166:302–310

    Article  PubMed  PubMed Central  Google Scholar 

  • Norrholm SD, Ressler KJ (2009) Genetics of anxiety and trauma-related disorders. Neuroscience 134:272–287

    Article  CAS  Google Scholar 

  • Noyes R, Hoehn-Saric R (1998) The anxiety disorders. Cambridge University Press, Cambridge

    Book  Google Scholar 

  • Noyes R, Reich J, Christiansen J et al (1990) Outcome of panic disorder: relationship to diagnostic subtypes and comorbidity. Arch Gen Psychiatry 47:809–818

    Article  PubMed  Google Scholar 

  • Noyes R, Woodman C, Garvewy MJ et al (1992) Generalized anxiety disorder vs. panic disorder: distinguishing characteristics and patterns of comorbidity. J Nerv Ment Dis 180:369–379

    Article  PubMed  Google Scholar 

  • Noyes R, Moroz G, Davidson JRT et al (1997) Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol 17:247–254

    Article  CAS  PubMed  Google Scholar 

  • Nutt DJ (2001) Neurobiological mechanisms in generalized anxiety disorder. J Clin Psychiatry 62(Suppl 11):22–27

    CAS  PubMed  Google Scholar 

  • Nutt DJ (2005) Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr 10:49–56

    Article  PubMed  Google Scholar 

  • Nutt DJ, Malizia AL (2001) New insights into the role of the GABAA-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 179:390–396

    Article  CAS  PubMed  Google Scholar 

  • Nutt DJ, Forshalll S, Bell C et al (1999) Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. Eur Neuropsychopharmacol 9:S81–S86

    Article  CAS  PubMed  Google Scholar 

  • Ohara K, Suzuki Y, Ochiai M et al (1999) A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders. Prog Neuropsychopharmacol Biol Psychiatry 23:55–65

    Article  CAS  PubMed  Google Scholar 

  • Öhman A, Mineka S (2001) Fears, phobias, and preparedness: toward an evolved module of fear and fear learning. Psychol Rep 198:483–522

    Article  Google Scholar 

  • Olatunji BO, Wolitzky-Taylor KB (2009) Anxiety sensitivity and the anxiety disorder: a meta-analytic review and synthesis. Psychol Bull 135:974–999

    Article  PubMed  Google Scholar 

  • Olatunji BO, Forsyth JP, Cherian A (2007) Evaluative differential conditioning of disgust: a sticky form or relational learning that is resistant to extinction. J Anxiety Disord 21:820–834

    Article  PubMed  Google Scholar 

  • Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B (2012) The economic cost of brain disorders in Europe. Eur J Neurol 19:155–162

    Article  CAS  PubMed  Google Scholar 

  • Olivier B, van Wijngaarden I, Soudijn W (2000) 5-HT3 receptor antagonists and anxiety: a preclinical and clinical view. Eur Neuropsychopharmacol 10:77–95

    Article  CAS  PubMed  Google Scholar 

  • Olsson A, Nearing KI, Phelps EA (2007) Learning fears by observing others: the neural systems of social fear transmission. Soc Cogn Affect Neurosci 2:3–12

    Article  PubMed  PubMed Central  Google Scholar 

  • Oosterink FM, de Jongh A, Hoogstraten J (2009) Prevalence of dental fear and phobia relative to other fear and phobia subtypes. Eur J Oral Sci 117:135–143

    Article  PubMed  Google Scholar 

  • Opris D, Pintea S, Garcia-Palacios A, Botella C, Szamoskozi S, David D (2012) Virtual reality exposure therapy in anxiety disorders: a quantitative meta-analysis. Depress Anxiety 29:85–93

    Article  PubMed  Google Scholar 

  • Ormel J, Oldehinkel T, Brilman E (1993) Outcome of depression and anxiety in primary care. Arch Gen Psychiatry 50:759–766

    Article  CAS  PubMed  Google Scholar 

  • Öst LG (1997) Rapid treatment of specific phobias. In: Davey GCL (Hrsg) Phobias. Wiley, New York, S 227–246

    Google Scholar 

  • Öst LG (2000) Spezifische Phobien. In: Margraf J (Hrsg) Lehrbuch der Verhaltenstherapie, Bd 2, 2. Aufl. Springer, Berlin/Heidelberg/New York/Tokio, S 29–42

    Chapter  Google Scholar 

  • Öst LG (2008) Efficacy of the third wave of behavioral therapies: a systematic review and meta-analysis. Behav Res Ther 46(3):296–321

    Article  PubMed  Google Scholar 

  • Otto MW, Powers M, Smits JAJ (2005) Adding cognitive-behavioral therapy to pharmacotherapy for panic disorder. Issues and strategies. CNS Spectr 9:32–39

    Article  CAS  Google Scholar 

  • Otto MW, Behar E, Smits JAJ, Hofmann ST (2009) Combining pharmacological and cognitive behavioral therapy in the treatment of anxiety disorders. In: Stein DJ, Hollander E, Rothbaum BO (Hrsg) Anxiety disorders, 2. Aufl. American Psychiatric Publishing, Washington, DC/London, S 429–440

    Google Scholar 

  • Otto MW, Tolin DF, Simon NM et al (2010) Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry 67:365–370

    Article  CAS  PubMed  Google Scholar 

  • Ouimet AJ, Gawronski B, Dozois DJ (2009) Cognitive vulnerability to anxiety: a review and an integrative model. Clin Psychol Rev 29:459–470

    Article  PubMed  Google Scholar 

  • Oyebode F (2008) Sim’s symptoms in the mind. An introduction to descriptive psychopathology, 4. Aufl. Saunders, Elsevier, Edinburgh/London/New York

    Google Scholar 

  • Palombo J, Bendicsen HK, Koch BJ (2009) Guide to psychoanalytic developmental theories. Springer, Berlin/Heidelberg/New York

    Google Scholar 

  • Pande AC, Davidson JR, Jefferson JW et al (1999) Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 19:341–348

    Article  CAS  PubMed  Google Scholar 

  • Pande AC, Crockatt JG, Feltner DE et al (2003) Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 160:533–540

    Article  PubMed  Google Scholar 

  • Pande AC, Feltner DE, Jefferson JW et al (2004) Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebocontrolled, multicenter study. J Clin Psychopharmacol 24:141–149

    Article  CAS  PubMed  Google Scholar 

  • Pané-Farré CA, Stender JP, Fenske K, Deckert J, Reif A, John U, Schmidt CO, Schulz A, Lang T, Alpers GW, Kircher T, Vossbeck-Elsebusch AN, Grabe HJ, Hamm AO (2014) The phenomenology of the first panic attack in clinical and community-based samples. J Anxiety Disord 28(6):522–529. doi:10.1016/j.janxdis.2014.05.009. Epub 2 June 2014

    Google Scholar 

  • Panksepp J (1998) Affective neuroscience. The foundations of human and animal emotions. Oxford University Press, Oxford

    Google Scholar 

  • Papazisis G, Tzachanis D (2014) Pregabalin’s abuse potential: a mini review focusing on the pharmacological profile. Int J Clin Pharmacol Ther 52:709–716

    Article  CAS  PubMed  Google Scholar 

  • Pape HC, Jüngling K, Seidenbecher T, Lesting J, Reinscheid RK (2010) Neuropeptide S: a transmitter system in the brain regulating fear and anxiety. Neuropharmacology 58(1):29–34

    Article  CAS  PubMed  Google Scholar 

  • Paquette V, Levesque J, Mensour B et al (2003) Change the mind and you change the brain: effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage 18:401–409

    Article  PubMed  Google Scholar 

  • Paulus MP, Stein MB (2006) An insular view of anxiety. Biol Psychiatry 60:383–387

    Article  PubMed  Google Scholar 

  • Perna G, Dario A, Caldirola D et al (2001) Panic disorder: the role of balance system. J Psychiatr Res 35:279–286

    Article  CAS  PubMed  Google Scholar 

  • Peterson RA, Reiss S (1987) Anxiety sensitivity index manual. International Diagnostic Systems, Orland Park

    Google Scholar 

  • Pezewas L, Meyer-Lindenberg A, Drabant EM et al (2005) 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8:828–834

    Article  CAS  Google Scholar 

  • Pfleiderer B, Zinkirciran S, Arolt V, Heindel W, Deckert J, Domschke K (2007) fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder. World J Biol Psychiatry 8(4):269–272

    Article  PubMed  Google Scholar 

  • Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME (2006) Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry 59:424–429

    Article  PubMed  Google Scholar 

  • Pissiota A, Frans O, Michelgard A et al (2003) Amygdala and anterior cingulated cortex activation during affective startle modulation: a PET study of fear. Eur J Neurosci 18:1325–1331

    Article  PubMed  Google Scholar 

  • Pohl R, Yeragani VK, Balon R (1988) Isoproterenol-induced panic attacks. Biol Psychiatry 24:891–902

    Article  CAS  PubMed  Google Scholar 

  • Pohl RB, Feltner DE, Fieve RR, Pande AC (2005) Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing. J Clin Psychopharmacol 25:151–158

    Article  CAS  PubMed  Google Scholar 

  • Pollack MH (2005) The pharmacotherapy of panic disorder. J Clin Psychiatry 66(Suppl 4):23–27

    CAS  PubMed  Google Scholar 

  • Pollack MH (2009) Refractory generalized anxiety disorder. J Clin Psychiatry 2:32–38

    Article  Google Scholar 

  • Pollack MH, Otto MW, Sabatino S et al (1996) Relationship of childhood anxiety to adult panic disorder: correlates and influence on course. Am J Psychiatry 153:376–381

    Article  CAS  PubMed  Google Scholar 

  • Pollack MH, Zaninelli R, Goddard A et al (2001) Paroxetine in the treatment of generalized anxiety disorder: results of a placebo controlled, flexible-dosage trial. J Clin Psychiatry 62:350–357

    Article  CAS  PubMed  Google Scholar 

  • Pollack MH, Simon NM, Zalta AK et al (2006) Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biol Psychiatry 59:211–215

    Article  CAS  PubMed  Google Scholar 

  • Pollack M, Mangano R, Entsuah R et al (2007) A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology (Berl) 194:233–242

    Article  CAS  Google Scholar 

  • Ponniah K, Hollon SD (2008) Empirically supported psychological interventions for social phobia in adults: a qualitative review of randomized controlled trials. Psychol Med 38:3–14

    Article  CAS  PubMed  Google Scholar 

  • Pontoski KE, Heimberg RG, Turk CL, Coles M (2009) Psychotherapy for social anxiety disorder. In: Stein DJ, Hollander, Rothbaum BO (Hrsg) Textbook of anxiety disorders. American Psychiatric Publishing, Washington, DC/London, S 501–521

    Google Scholar 

  • Poulton R, Menzies RG (2002) Non-associative fear acquisition: a review of the evidence from retrospective and longitudinal research. Behav Res Ther 40:127–149

    Article  PubMed  Google Scholar 

  • Powers MB, Smits JA, Otto MW et al (2009) Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation. J Anxiety Disord 23:350–356

    Article  PubMed  Google Scholar 

  • Prasko J, Dockery C, Horacek J et al (2006) Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up. Neuro Endocrinol Lett 27(4):473–481

    CAS  PubMed  Google Scholar 

  • Rachman S (1977) The conditioning theory of fear-acquisition: a critical examination. Behav Res Ther 15:375–387

    Article  CAS  PubMed  Google Scholar 

  • Rachman SJ (1991) Neoconditioning and the classical theory of fear acquisition. Clin Psychol Rev 11:155–173

    Article  Google Scholar 

  • Raffa SD, Stoddard JA, White KS (2008) Relapse following combined treatment discontinuation in a placebo controlled trial for panic disorder. J Nerv Ment Dis 196:548–555

    Article  PubMed  Google Scholar 

  • Rapee RM (2013) The preventative effects of a brief, early intervention for preschool-aged children at risk for internalising: follow-up into middle adolescence. J Child Psychol Psychiatry 54:780–788

    Article  PubMed  Google Scholar 

  • Rapee RM, Bryant RA (2009) Stress and psychosocial factors in onset of fear circuitry disorders. In: Andrews G, Charney DS, Sirovatka PJ, Regier DA (Hrsg) Stress-induced and fear circuitry disorders. Advancing the research agenda for DSM-V. American Psychiatric Association, Arlington, VA, S 195–214

    Google Scholar 

  • Rapee RM, Schniering CA, Hudson JL (2009) Anxiety disorders during childhood and adolescence: origins and treatment. Annu Rev Clin Psychol 5:311–341

    Article  PubMed  Google Scholar 

  • Rauch SL, Drevets WC (2009) Neuroimaging and neuroanatomy of stress-induced and fear circuitry disorders. In: Andrews G, Charney DS, Sirovatka PJ, Regier DA (Hrsg) Stress-induced and fear circuitry disorders. Advancing the research agenda for DSM-V. American Psychiatric Association, Arlington, VA, S 215–254

    Google Scholar 

  • Rauch LS, Savage CR, Alpert NM et al (1995) A positron emission tomography study of simple phobic symptom provocation. Arch Gen Psychiatry 52:20–28

    Article  CAS  PubMed  Google Scholar 

  • Reif A, Richter J, Straube B, Höfler M, Lueken U, Gloster AT, Weber H, Domschke K, Fehm L, Ströhle A, Jansen A, Gerlach A, Pyka M, Reinhardt I, Konrad C, Wittmann A, Pfleiderer B, Alpers GW, Pauli P, Lang T, Arolt V, Wittchen HU, Hamm A, Kircher T, Deckert J (2014) MOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Mol Psychiatry 19(1):122–128

    Article  CAS  PubMed  Google Scholar 

  • Ressler KJ, Rothbaum BO, Tannenbaum L et al (2004) Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61:1136–1144

    Article  PubMed  Google Scholar 

  • Richter J, Hamm AO, Pané-Farré CA, Gerlach AL, Gloster AT, Wittchen HU, Lang T, Alpers GW, Helbig-Lang S, Deckert J, Fydrich T, Fehm L, Ströhle A, Kircher T, Arolt V (2012) Dynamics of defensive reactivity in patients with panic disorder and agoraphobia: implications for the etiology of panic disorder. Biol Psychiatry 72(6):512–520. doi:10.1016/j.biopsych.2012.03.035. Epub 22 May 2012

    Google Scholar 

  • Rickels K (1978) Use of antianxiety agents in anxious outpatients. Psychopharmacology 58:1–17

    Article  CAS  PubMed  Google Scholar 

  • Rickels K, Pollack MH, Sheehan DV et al (2000b) Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry 157:968–974

    Article  CAS  PubMed  Google Scholar 

  • Rickels K, Zaninelli R, McCafferty J et al (2003) Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study. Am J Psychiatry 160:749–756

    Article  PubMed  Google Scholar 

  • Rickels K, Mangano R, Khan A (2004) A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder. J Clin Psychopharmacol 24:488–496

    Article  CAS  PubMed  Google Scholar 

  • Rickels K, Pollack MH, Feltner DE et al (2005) Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry 62:1022–1103

    Article  CAS  PubMed  Google Scholar 

  • Robichaud M, Dugas MJ (2009) Psychological treatment of generalized anxiety disorder. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 364–374

    Google Scholar 

  • Rocah BS (1991) A clinical study of a phobic illness: the effects of traumatic scars on symptom formation and treatment. Psychoanal Inq 11:351–375

    Article  Google Scholar 

  • Rocca P, Fonzo V, Scotta M et al (1997) Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 95:444–450

    Article  CAS  PubMed  Google Scholar 

  • Rodebaugh TL, Holaway RM, Heimberg RG (2004) The treatment of social anxiety disorder. Clin Psychol Rev 24:883–908

    Article  PubMed  Google Scholar 

  • Rodriguez BF, Weisberg RB, Pagano ME et al (2006) Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patients. J Nerv Ment Dis 194:91–97

    Article  PubMed  PubMed Central  Google Scholar 

  • Roelofs K, van Peer J, Berretty E et al (2009) Hypothalamus-pituitary-adrenal axis hyperresponsiveness is associated with increased social avoidance behaviour in social phobia. Biol Psychiatry 65:336–343

    Article  CAS  PubMed  Google Scholar 

  • Roemer L, Orsillo SM (2007) An open trial of an acceptance-based behavior therapy for generalized anxiety disorder. Behav Ther 38:72–85

    Article  PubMed  Google Scholar 

  • Rollman BL, Belnap BH, Mazumdar S et al (2005) A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiatry 62:1332–1342

    Article  PubMed  Google Scholar 

  • Roozendaal B, Okuda S, de Quervain DJ, McGaugh JL (2006) Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions. Neuroscience 138:901–910

    Article  CAS  PubMed  Google Scholar 

  • Roozendaal B, McEwen BS, Chattarji S (2009) Stress, memory and the amygdale. Nat Rev Neurosci 10:423–433

    Article  CAS  PubMed  Google Scholar 

  • Rosenthal M (2003) Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control. J Clin Psychiatry 64:1245–1249

    Article  CAS  PubMed  Google Scholar 

  • Ross LE, McLean LM (2006) Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry 67:1285–1298

    Article  PubMed  Google Scholar 

  • Roth M (1960) The phobic anxiety-depersonalization syndrome and some general aetiological problems in psychiatry. J Neuropsychiatry 1:293–306

    CAS  Google Scholar 

  • Roth A, Fonagy P (2005) What works for whom? A critical review of psychotherapy research, 2. Aufl. Guilford, New York/London

    Google Scholar 

  • Rothschild AJ, Mahableshwarkar AR, Jacobsen P, Yan M, Sheehan DV (2012) Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States. Eur Neuropsychopharmacol 22:858–866

    Article  CAS  PubMed  Google Scholar 

  • Roy-Byrne PP, Craske MG, Stein MB et al (2005) A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 62:290–298

    Article  PubMed  PubMed Central  Google Scholar 

  • Roy-Byrne P, Veitengruber JP, Bystritsky A et al (2009) Brief intervention for anxiety in primary care patients. J Am Board Fam Med 22:175–186

    Article  PubMed  PubMed Central  Google Scholar 

  • Rudolf G, Grande T, Porsch U (1988) Die Berliner Psychotherapiestudie. Z Psychosom Med Psychoanal 34:2–18

    CAS  PubMed  Google Scholar 

  • Rudolf G, Manz R, Öri C (1994) Ergebnisse psychoanalytischer Therapien. Z Psychosom Med Psychoanal 40:25–40

    CAS  PubMed  Google Scholar 

  • Ruhmland M, Margraf J (2001) Effektivität psychologischer Therapien von spezifischer Phobie und Zwangsstörung: Meta-Analysen auf Störungsebene. Verhaltenstherapie 11:14–26

    Article  Google Scholar 

  • Ruscio AM, Lane M, Roy-Byrne P et al (2005) Department of Health Care Policy. Psychol Med 35:1761–1772

    Article  PubMed  PubMed Central  Google Scholar 

  • Rynn MA, Brawman-Mintzer O (2004) Generalized anxiety disorder: acute and chronic treatment. CNS Spectr 9:716–723

    Article  PubMed  Google Scholar 

  • Rynn M, Russell J, Erickson J et al (2008) Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible dose, progressive titration, placebo-controlled trial. Depress Anxiety 25:182–189

    Article  CAS  PubMed  Google Scholar 

  • Salzer S, Winkelbach C, Leweke F, Leibing E, Leichsenring F (2011) Long-term effects of short-term psychodynamic psychotherapy and cognitive-behavioural therapy in generalized anxiety disorder: 12-month follow-up. Can J Psychiatry 56(8):503–508

    Article  PubMed  Google Scholar 

  • Samochowiec J, Hajduk A, Samochowiec A et al (2004) Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res 128:21–26

    Article  CAS  PubMed  Google Scholar 

  • Sánchez-Meca J, Rosa-Alcázar AI, Marín-Martínez F, Gómez-Conesa A (2010) Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. Clin Psychol Rev 30:37–50

    Article  PubMed  Google Scholar 

  • Sareen J, Cox BJ, Clara I, Asmundson GJ (2005) The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey. Depress Anxiety 21(4):193–202

    Article  PubMed  Google Scholar 

  • Sareen J, Chartier M, Paulus MP, Stein MB (2006) Illicit drug use and anxiety disorders: findings from two community surveys. Psychiatry Res 142:11–17

    Article  PubMed  Google Scholar 

  • Sarlo M, Buodo G, Munafó M et al (2008) Cardiovascular dynamics in blood phobia: evidence for a key role of sympathetic activity in vulnerability to syncope. Psychophysiology 45:1038–1045

    Article  PubMed  Google Scholar 

  • Sartorius N, Ustun TB, Lecrubier U et al (1996) Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry 168:38–43

    Article  Google Scholar 

  • Scheibe G, Tress W, Reister G (1997) Psychoanalytische Modellvorstellungen und die DSM-IV-Klassifikation von Angststörungen: Widerspruch oder Ergänzung? Z Psychosom Med Psychoanal 43:138–152

    Google Scholar 

  • Schienle A, Schafer A, Walter B et al (2005) Brain activation of spider phobics towards disorder-relevant, generally disgust- and fear-inducing pictures. Neurosci Lett 388:1–6

    Article  CAS  PubMed  Google Scholar 

  • Schienle A, Schäfer A, Stark R, Vaitl D (2009) Long-term effects of cognitive behaviour therapy on brain activation in spider phobia. Psychiatry Res 172:99–102

    Article  PubMed  Google Scholar 

  • Schneier FR (2005) Neurobiological mechanisms of social anxiety disorder. CNS Spectr 10(Suppl 13):8–9

    Google Scholar 

  • Schneier FR, Goetz D, Campeas R et al (1998) Placebo-controlled trial of moclobemide in social phobia. Br J Psychiatry 172:70–77

    Article  CAS  PubMed  Google Scholar 

  • Schneier FR, Liebowitz MR, Abi-Dargham A et al (2000) Low dopamine D2 receptor binding potential in social phobia. Am J Psychiatry 157:457–459

    Article  CAS  PubMed  Google Scholar 

  • Schneier FR, Abi-Dargham A, Martinez D et al (2009) Dopamine transporters, D2 receptors, and dopamine release in generalized social and anxiety disorder. Depress Anxiety 26:411–418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schuebel K, Gitik M, Domschke K, Goldman D (2016) Making sense of epigenetics. Int J Neuropsychopharmacol 19:1–10

    Article  Google Scholar 

  • Schulz J, Gotto JG, Rapaport MH (2005) The diagnosis and treatment of generalized anxiety disorder. Prim Psychiatry 12:58–67

    Google Scholar 

  • Schuwald AM, Nöldner M, Wilmes T, Klugbauer N, Leuner K, Müller WE (2013) Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels. PLoS One 8:e59998

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Scott KM, Wells JE, Angermeyer M et al (2009) Gender and the relationship between marital status and first onset of mood, anxiety and substance use disorders. Psychol Med 26:1–11

    Google Scholar 

  • Seedat S, Scott KM, Angermeyer MC et al (2009) Cross-national associations between gender and mental disorders in World Health Organization World Mental Health Surveys. Arch Gen Psychiatry 66:785–795

    Article  PubMed  PubMed Central  Google Scholar 

  • Seligman MEP (1971) Phobias and preparedness. Behav Ther 2:307–320

    Article  Google Scholar 

  • Shear MK, Cooper AM, Klerman GL, Busch FN et al (1993) A psychodynamic model of panic disorder. Am J Psychiatry 150:859–866

    Article  CAS  PubMed  Google Scholar 

  • Shear MK, Pilkonis PA, Cloitre M, Leon AC (1994) Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder. Arch Gen Psychiatry 51:395–401

    Article  CAS  PubMed  Google Scholar 

  • Shear MK, Houck PM, Greeno C, Masters S (2001) Emotion-focused psychotherapy for patients with panic disorder. Am J Psychiatry 158:1993–1998

    Article  CAS  PubMed  Google Scholar 

  • Shear K, Jin R, Ruscio AM, Walters EE, Kessler RC (2006) Prevalence and correlates of estimated DSM-IV child and adult separation anxiety disorder in the National Comorbidity Survey Replication. Am J Psychiatry 163:1074–1083

    Article  PubMed  PubMed Central  Google Scholar 

  • Shiban Y, Pauli P, Mühlberger A (2013) Effect of multiple context exposure on renewal in spider phobia. Behav Res Ther 51(2):68–74

    Article  PubMed  Google Scholar 

  • Shiban Y, Schelhorn I, Pauli P, Mühlberger A (2015) Effect of combined multiple contexts and multiple stimuli exposure in spider phobia: a randomized clinical trial in virtual reality. Behav Res Ther 71:45–53

    Article  PubMed  Google Scholar 

  • Shin LM, Liberzon I (2010) The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35:169–191

    Article  PubMed  Google Scholar 

  • Shresta R, Natarajan N, Coplan JD (2009) Pathogeneis of panic disorder. In: Stein DJ, Hollander, Rothbaum BO (Hrsg) Textbook of anxiety disorders. American Psychiatric Publishing, Washington, DC/London, S 381–398

    Google Scholar 

  • Simon AB, Gorman JM (2006) Advances in the treatment of anxiety: targeting glutamate. NeuroRx 3:57–68

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Simon NM, Connor KM, LeBeau RT et al (2008) Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology (Berl) 197:675–681

    Article  CAS  Google Scholar 

  • Simon NM, Kaufmann RE, Hoge EA et al (2009a) Open-label support for duloxetine for the treatment of panic disorder. CNS Neurosci Ther 5:19–23

    Article  CAS  Google Scholar 

  • Simon NM, Otto MW, Worthington JJ et al (2009b) Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial. J Clin Psychiatry 70:1563–1570

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Simpson HB, Schneider FR, Campeas R et al (1998) Imipramine in the treatment of social phobia. J Clin Psychopharmacol 18:132–135

    Article  CAS  PubMed  Google Scholar 

  • Sinclair LI, Christmas DM, Hood SD, Potokar JP, Robertson A, Isaac A, Srivastava S, Nutt DJ, Davies SJ (2009) Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiatry 194(6):483–490

    Article  PubMed  Google Scholar 

  • Slaap BR, den Boer JA (2001) The prediction of nonresponse to pharmacotherapy in panic disorder: a review. Depress Anxiety 14:112–122

    Article  CAS  PubMed  Google Scholar 

  • Slade T, Andrews G (2001) DSM-IV and ICD-10 generalized anxiety disorder: discrepant diagnoses and associated disability. Soc Psychiatry Psychiatr Epidemiol 36:45–51

    Article  CAS  PubMed  Google Scholar 

  • Smits JAJ, Rosenfield D, Otto MW, Powers MB, Hofmann SG, Telch MJ, Pollack MH, Tart CD (2013) d-Cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biol Psychiatry 73:1054–1058

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Smoller JW, Simon NM, Pollack MH et al (1999) Anxiety in patients with pulmonary disease: comorbidity and treatment. Semin Clin Neuropsychiatry 4:84–97

    CAS  PubMed  Google Scholar 

  • Smoller JW, Yamaki LH, Fagerness JA et al (2005) The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol Psychiatry 57:1485–1492

    Article  CAS  PubMed  Google Scholar 

  • Smoller JD, Gardner-Schuster E, Covino J (2008) The genetics basis of panic and phobic anxiety disorders. Am J Med Genet Part C Semin Med Genet 148C:118–126

    Article  PubMed  Google Scholar 

  • Somers JM, Goldner EM, Waraich P, Hsu L (2006) Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry 51:100–113

    Article  PubMed  Google Scholar 

  • Soravia LM, Heinrichs M, Aerni A et al (2006) Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci U S A 103:5585–5590

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spielberger CD (Hrsg) (1966) Anxiety and behavior. Academic, New York

    Google Scholar 

  • Spielberger CD, Gorsuch RL, Lushene RE (1970) State-trait anxiety inventory („self-evaluation questionnaire“). Consulting Psychologists Press, Palo Alto

    Google Scholar 

  • Starcevic V (2008) Treatment of panic disorder: recent developments and current status. Expert Rev Neurother 8:1219–1232

    Article  CAS  PubMed  Google Scholar 

  • Starcevic V, Berle D (2006) Cognitive specificity of anxiety disorders: a review of selected key constructs. Depress Anxiety 23:51–61

    Article  PubMed  Google Scholar 

  • Steel Z et al (2014) The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. Int J Epidemiol 43:476–493

    Article  PubMed  PubMed Central  Google Scholar 

  • Stein DJ, Matsunaga H (2006) Specific phobia: a disorder of fear conditioning and extinction. CNS Spectr 11:248–251

    Article  PubMed  Google Scholar 

  • Stein MG, Stein DJ (2008) Social anxiety disorder. Lancet 371:1115–1125

    Article  PubMed  Google Scholar 

  • Stein MB, Uhde TW (1998) Biology of anxiety disorders. In: Schatzberg AF, Nemeroff CB (Hrsg) Textbook of psychopharmacology, 2. Aufl. American Psychiatric Press, Washington, DC, S 609–628

    Google Scholar 

  • Stein DJ, Berk M, Els C et al (1999) A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa. S Afr Med J 89:402–406

    CAS  PubMed  Google Scholar 

  • Stein DJ, Cameron A, Amrein R, Moclobemide Social Phobia Clinical Study Group et al (2002a) Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder. Int Clin Psychopharmacol 17:161–170

    Article  CAS  PubMed  Google Scholar 

  • Stein DJ, Versiani M, Hair T et al (2002b) Efficacy of paroxetine for relapse prevention on social anxeity disorder: a 24-week study. Arch Gen Psychiatry 59:1111–1118

    Article  CAS  PubMed  Google Scholar 

  • Stein MB, Goldin PR, Sareen J et al (2002c) Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 59:1027–1034

    Article  PubMed  Google Scholar 

  • Stein DJ, Westenberg HG, Yang H et al (2003) Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial. Int J Neuropsychopharmacol 6:317–323

    Article  CAS  PubMed  Google Scholar 

  • Stein MB, Pollack MH, Bystrritsky A et al (2005) Efficacy of low and higher dose extended – release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial. Psychopharmacology (Berl) 177:280–288

    Article  CAS  Google Scholar 

  • Stein MB, Seedat S, Gelernter J (2006) Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology (Berl) 187:68–72

    Article  CAS  Google Scholar 

  • Stein DJ, Ahokas AA, de Bodinat C (2008a) Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo controlled study. J Clin Psychopharmacol 28:561–566

    Article  CAS  PubMed  Google Scholar 

  • Stein DJ, Baldwin DS, Baldinetti F, Mandel F (2008b) Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies. Eur Neuropsychopharmacol 18:422–430

    Article  CAS  PubMed  Google Scholar 

  • Stein DJ, Bandelow B, Merideth C, Olausson B, Szamosi J, Eriksson H (2011) Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies. Hum Psychopharmacol 26:614–628

    Article  CAS  PubMed  Google Scholar 

  • Stein DJ, Ahokas A, Albarran C, Olivier V, Allgulander C (2012) Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study. J Clin Psychiatry 73:1002–1008

    Article  CAS  PubMed  Google Scholar 

  • Stein DJ, Ahokas A, Márquez MS, Höschl C, Oh KS, Jarema M, Avedisova AS, Albarran C, Olivier V (2014) Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study. J Clin Psychiatry 75:362–368

    Article  CAS  PubMed  Google Scholar 

  • Stinson FS, Dawson DA, Chou PS et al (2007) The epidemiology of DSM-IV specific phobia in the USA: results form the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 37:1047–1059

    Article  PubMed  Google Scholar 

  • Stocchi F, Nordera G, Jokinen RH et al (2003) Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder. J Clin Psychiatry 64:250–258

    Article  CAS  PubMed  Google Scholar 

  • Straube T, Mentzel HJ, Glauer M, Miltner WH (2004) Brain activation to phobia-related words in phobic subjects. Neurosci Lett 372:204–208

    Article  CAS  PubMed  Google Scholar 

  • Straube T, Glauer M, Dilger S et al (2006a) Effects of cognitive-behavioral therapy on brain activation in specific phobia. Neuroimage 29:125–135

    Article  PubMed  Google Scholar 

  • Straube T, Mentzel HJ, Miltner WH (2006b) Neural mechanisms of automatic and direct processing of phobogenic stimuli in specific phobia. Biol Psychiatry 59:162–170

    Article  PubMed  Google Scholar 

  • Straube B, Reif A, Richter J, Lueken U, Weber H, Arolt V, Jansen A, Zwanzger P, Domschke K, Pauli P, Konrad C, Gerlach AL, Lang T, Fydrich T, Alpers GW, Ströhle A, Wittmann A, Pfleiderer B, Wittchen HU, Hamm A, Deckert J, Kircher T (2014) The functional -1019C/G HTR1A polymorphism and mechanisms of fear. Transl Psychiatry 4:e490

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Strauss B, Burgmeier-Lohse M (1994) Evaluation einer stationären Langzeitgruppenpsychotherapie. Ein Beitrag zur differentiellen Psychotherapieforschung im stationären Feld. Psychother Psychosom Med Psychol 44:184–192

    CAS  PubMed  Google Scholar 

  • Stravynski A, Arbel N, Bounader J et al (2000) Social phobia treated as a problem in social functioning: a controlled comparison of two behavioural group approaches. Acta Psychiatr Scand 102:188–198

    Article  CAS  PubMed  Google Scholar 

  • Ströhle A, Kellner M, Yassouridis A et al (1998) The effects of flumazenil in lactate-sensitive patients with panic disorder. Am J Psychiatry 155:610–612

    Article  PubMed  Google Scholar 

  • Suárez LM, Bennett SM, Goldstein CR, Barlow DH (2009) Understanding anxiety disorders from a „tripple vulnerability“ framework. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 153–172

    Google Scholar 

  • Susman J, Klee B (2005) The role of high-potency benzodiazepines in the treatment of panic disorder. Prim Care Companion J Clin Psychiatry 7:5–11

    Article  PubMed  PubMed Central  Google Scholar 

  • Tancer ME, Stein MB, Uhde TW (1993) Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers. Biol Psychiatry 34:591–595

    Article  CAS  PubMed  Google Scholar 

  • Taylor J (1953) A personality scale of manifest anxiety. J Abnorm Soc Psychol 48:285–290

    Article  CAS  Google Scholar 

  • Taylor S (1996) Meta-analysis of cognitive-behavioral treatments for social phobia. J Behav Ther Exp Psychiatry 27:1–9

    Article  CAS  PubMed  Google Scholar 

  • Thase ME, Jindal RD (2004) Combining psychotherapy and psychopharmacology for treatment of mental disorders. In: Lambert MJ (Hrsg) Bergin and Garfield’s handbook of psychotherapy and behaviour change, 5. Aufl. Wiley, New York, S 743–766

    Google Scholar 

  • Thoeringer CK, Binder EB, Salyakina D et al (2007) Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. J Psychiatr Res 41:579–584

    Article  PubMed  Google Scholar 

  • Tiihonen J, Kuikka J, Bergstrom K et al (1997a) Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 154:239–242

    Article  CAS  PubMed  Google Scholar 

  • Tiihonen J, Kuikka J, Rasanen P et al (1997b) Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis. Mol Psychiatry 2:463–471

    Article  CAS  PubMed  Google Scholar 

  • Tillfors M, Furmark T, Marteinsdottir I et al (2001) Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. Am J Psychiatry 158:1220–1226

    Article  CAS  PubMed  Google Scholar 

  • Tillfors M, Furmark T, Marteinsdottir I, Fredrikson M (2002) Cerebral blood flow during anticipation of public speaking in social phobia: a PET study. Biol Psychiatry 52:1113–1119

    Article  PubMed  Google Scholar 

  • Tolin DF, Gilliam CM, Dufresne D (2009) The economic and social burden of anxiety disorders. In: Stein DJ, Hollander, Rothbaum BO (Hrsg) Textbook of anxiety disorders. American Psychiatric Publishing, Washington, DC/London, S 731–746

    Google Scholar 

  • Torgersen S (1979) The nature and origin of common phobic fears. Br J Psychiatry 40:1085–1089

    Google Scholar 

  • Trower P, Gilbert P (1989) New theoretical conceptions of social anxiety and social phobia. Clin Psychol Rev 9:19–35

    Article  Google Scholar 

  • Trull TJ, Nietzel MT, Maier A (1988) The use of meta-analysis to assess the clinical significance of behavior therapy for agoraphobia. Behav Ther 19:527–538

    Article  Google Scholar 

  • Tyrer P (1992) Anxiolytics not acting at the benzodiazepine receptor: beta blockers. Prog Neuropsychopharmacol Biol Psychiatry 16:17–26

    Article  CAS  PubMed  Google Scholar 

  • Tyrer P, Seivewright H, Johnson D (2004) The Nottingham Study of Neurotic Disorder: predictors of 12-year outcome of dysthymic, panic and generalized anxiety disorder. Psychol Med 34:1385–1394

    Article  PubMed  Google Scholar 

  • Ulrich-Lai YM, Herman JP (2009) Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 10:397–409

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Van Ameringen M, Mancini C, Szechtman H et al (2004) A PET provocation study of generalized social phobia. Psychiatry Res 132:13–18

    Article  PubMed  Google Scholar 

  • Van Ameringen M, Mancini C, Patterson B (2009) Pharmacotherapy for social anxiety disorder and specific phobia. In: Anthony MM, Stein MB (Hrsg) Oxford handbook of anxiety and related disorders. Oxford library of psychology. Oxford University Press, Oxford, S 321–333

    Google Scholar 

  • Van Balkom AJ, Bakker A, Spinhoven P et al (1997) A meta-analysis of the treatment of panic disorder with and without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis 185:510–516

    Article  PubMed  Google Scholar 

  • Van Balkom AJ, van Boeijen CA, Boeke AJ et al (2008) Comorbid depression, but not comorbid anxiety disorders, predicts poor outcome in anxiety disorders. Depress Anxiety 25:405–415

    Google Scholar 

  • Van der Linden G, van der Heerden B, Warwick J et al (2000) Functional brain imaging and pharmacotherapy in social phobia: single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Prog Neuropsychopharmacol Biol Psychiatry 24:419–438

    Article  PubMed  Google Scholar 

  • Van der Wee NJ, van Veen JF, Stevens H et al (2008) Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 1231-beta-(4-iodophenyl)-tropane SPECT. J Nucl Med 49:757–763

    Article  PubMed